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1.  Introduction 
1.1  Issue 
An estimated one million metric tons of commercial mixtures of polychlorinated 
biphenyls (PCBs), such as Aroclors (USA),  Kanechlors (Japan) and Clophens 
(Germany), were manufactured (WHO, 1993) and used worldwide as dielectric fluids in 
capacitors and transformers, heat transfer fluids, hydraulic fluids, lubricating oils, and as 
additives in pesticides, paints, copy paper, adhesives and plastics during the 1930s 
through the mid-1970s.  PCBs have entered the environment during both use and disposal 
and have been shown to be ubiquitous contaminants, occurring in most environmental 
media as well as biota. 
Historically, analyses of environmental media and associated risk assessments have been 
conducted using approaches that consider the PCB mixtures as a whole, i.e., “Total 
PCBs” or Aroclors.  Subsequently, it has been shown that the fate of various congeners in 
the environment varies, such that the PCB congener profiles in environmental media may 
change significantly from the original commercial mixtures.  Likewise, individual PCB 
congeners have been found to vary significantly in their uptake, distribution, metabolism, 
and elimination within biological systems such that the congener profile in biological 
tissues can be quite different from both the original commercial PCB mixture and 
environmental media.  Toxicological effects and dose-response relationships within 
biological systems can also vary among the different PCB congeners. 
As a result, the consensus within the scientific community is that “Total PCB”- and/or 
Aroclor-based risk analyses may not adequately characterize risks posed by PCB mixtures 
(WHO, 2001).  Those PCB congeners that elicit dioxin-like toxicity have been defined 
and a toxicity equivalence approach for use in both human health and ecological risk 
assessment has been developed (U.S. EPA, 2000, 2001, 2003).  However, the dioxin-like 
PCB congeners represent only 12 of the 209 possible congeners.  To assess risks posed by 
the remaining 197 congeners, information on the fate and effects of the non-dioxin-like 
congeners is required. 
1.2  Purpose of this Report 
  To provide ecological risk assessors with a concise summary of the state-of-the-
science regarding the biological effects of non-dioxin-like PCBs. 
  To provide ecological risk assessors with a compilation of references describing 
the biological effects of non-dioxin-like PCBs.  The list of references is comprised 
primarily of books, reports, and review articles to provide risk assessors with 
sources from which they may acquire a thorough overview of the topics at hand. 
These materials should be used as a source for primary literature references. 
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1.3	 ERASC Request & Response 
The issues addressed in this report are those specifically requested in the Ecological Risk 
Assessment Support Center Request Form (Appendix 2).  These issues are listed below 
along with the section(s) of the report where the information addressing each issue can be 
located. 
	 Describe the mode of action of non-dioxin-like compounds and types of effects in 
receptors (i.e., those congeners that "travel" with the listed dioxins, furans, and 
PCBs but just don't act via the Ah receptor) 
Addressed in Section 4. 
	 Discuss n-d-l toxicity relative to congener characteristics (something like a QSAR 
discussion of planes and rings and big chlorines) 
Addressed in Sections 2 & 4. 
	 Discuss which congeners are of greatest concern (potency) for n-d-l toxicity 
(dose/response type information in the narcotic range of effects) 
Addressed in Sections 3 & 4. 
	 Recommend how this scientific info on action, effects, and toxicity should be used 
in eco risk assessment where PCBs are present (preferred use of the data, 
considerations for site-specific application, etc.) 
Addressed in Section 5. 
	 Discuss whether a general narcosis model can or should be used to evaluate n-d-l 
effects (as a function of range of contaminant concentration typically seen at low, 
medium, and highly contaminated sites) 
Addressed in Sections 4 & 5. 
	 Provide an interactive video-conference on this topic and the one related to 
congener analytical methodology 
This portion of the request requires another process. 
2 2.  Chemical Characterization 
A brief overview of PCB nomenclature and chemical properties is provided in this 
section.  Several detailed compilations of PCB chemistry and nomenclature have been 
compiled previously for all PCBs (Erickson, 1997, 2001; ATSDR, 2000) and for non-
dioxin-like PCBs (Hansen, 1999). 
2.1  Chemical Structure 
Figure 1.  Structure PCBs. 
2.2  Nomenclature 
Polychlorinated biphenyls (PCBs) are a class of chemicals characterized by a common 
biphenyl molecular framework to which 2 to 10 chlorine atoms may be attached (Figure 
1).  Although technically not  polychlorinated, mono-chlorinated biphenyls are generally 
included when referring to PCBs collectively.   
Congener - one of 209 possible PCB structures having the formula, C12H 10-nCln, where n 
= 1-10.  Each of the 209 PCB congeners can be specifically defined by standard chemical 
nomenclature rules in which the number and position of chlorines on the biphenyl ring(s) 
are designated.  Each PCB congener has also been assigned a number, between 1 and 209, 
by the International Union of Pure and Applied Chemists (IUPAC).  The IUPAC numbers 
provide a convenient shorthand system, but do not provide information as to the specific 
chemical identity of the congener.  A list of all 209 PCB congeners, including IUPAC 
name, IUPAC # and CAS # are provided in Appendix 1. 
Homolog - a subset of PCB congeners defined by the degree of chlorination, i.e., 
monochlorobiphenyls through decachlorobiphenyls (Table 1).  PCBs within a homolog 
group have the same molecular weight and number of chlorines attached to the biphenyl 
ring, but the pattern of chlorination varies among the individual isomers within the 
homolog group.  A list of all PCB homolog groups, including IUPAC name and CAS # 
are provided in Appendix 1. 
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 Table 1.  Chemical Groupings of Polychlorinated Biphenyls 
Number of 
Chlorines 
Homolog 
Group 
Molecular 
Formula 
Molecular 
Weight 
Number of 
Isomers 
0  biphenyl  C12H10  154.1  1 
1  mono-CB  C12H9Cl  188.0  3 
2  di-CB  C12H8Cl2  222.0  12 
3  tri-CB  C12H7Cl3  256.0  24 
4  tetra-CB  C12H6Cl4  289.9  42 
5  penta-CB  C12H5Cl5  323.9  46 
6  hexa-CB  C12H4Cl6  357.8  42 
7  hepta-CB  C12H3Cl7  391.8  24 
8  octa-CB  C12H2Cl8  425.8  12 
9  nona-CB  C12HCl9  459.7  3 
10  deca-CB  C12Cl10  493.7  1 
Isomer - biphenyls within the same homolog group (i.e., same molecular weight and 
molecular formula) with different substitution patterns.  Specific isomers are defined by 
the position(s) of the chlorine atoms on the biphenyl rings (e.g., 3,3',4,4',5-
pentachlorobiphenyl). 
2.3  Physical-Chemical Characteristics 
Most pure PCB congeners are colorless, odorless crystals under ambient conditions 
(Erickson, 2001).  Commercial PCB mixtures (e.g. Aroclors) are clear, viscous liquids, 
with viscosity increasing with degree of chlorination.  Generally, PCBs have high boiling 
points (>200°C), low vapor pressures, low water solubilities (ppm to ppt), moderate to 
high log Kows (~4 to 8), high bioconcentration factors (BCFs) and do not degrade readily, 
which all contribute to their persistence in the environment.  These physical-chemical 
properties may vary widely between the individual congeners.  A summary of these 
properties, presented as averages for homolog group (Erickson, 2001) and for individual 
congeners (Hansen, 1999), have been compiled.  High quality Log Kow values for all 209 
PCB congeners, as determined by Hawker and Connell (1988), are provided in Appendix 
1 for reference.  Primary sources of information on specific congener properties are 
referenced within these summaries. 
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2.4  Dioxin-Like PCB Congeners 
The 12 PCBs listed in Table 2 act through the aryl hydrocarbon receptor (AHR) to cause 
the full range of toxic responses elicited by 2,3,7,8-tetrachlorodibenzo-p-dioxin.  Hence, 
these PCB congeners are referred to as the dioxin-like PCBs.  The structure-activity 
relationships underlying the distinction of dioxin-like PCBs from the other PCBs have 
been characterized.  The dioxin-like PCBs have chlorines in a minimum of four of the 
lateral positions (i.e., 3, 3', 4, 4', 5, 5') and none (non-) or only one (mono-) of the ortho 
positions (i.e., 2, 2', 6, or 6') of the biphenyl.  The PCBs without ortho substituted 
chlorines are often referred to as co-planar PCBs, but this terminology is not technically 
appropriate since these PCBs do not easily assume a planar conformation similar to that 
of the dioxins and furans (WHO, 2001).  The non-ortho dioxin-like PCBs (i.e., PCBs 77, 
81, 126 & 169) bind the AHR and cause dioxin-like toxicity in fish, birds and mammals. 
The mono-ortho chlorinated dioxin-like PCBs are also able to bind the AHR and cause 
dioxin-like toxicity in birds and mammals, but generally do not cause dioxin-like 
responses in fish.  The toxicological effects which may occur, as a result of exposure to 
dioxin-like PCBs in fish, birds and mammals, have been well characterized relative to the 
other PCBs.  Dioxin-like toxicity in ecological receptors has been summarized in the 
scientific literature and in numerous EPA reports (Peterson et al., 1993; Walker and 
Peterson, 1994; Niimi, 1996; Hoffman et al., 1996; Rice et al., 2002; ATSDR, 2000; U.S. 
EPA, 1993, 1995a,b, 2001) and will not be discussed in detail further in this report. 
Table 2.  Dioxin-Like PCBs 
IUPAC #  Homolog Group  Substitution Group  IUPAC Name 
non-ortho substituted PCBs 
77  tetra-CB  non-ortho  3,3',4,4'-tetra-CB 
81  tetra-CB  non-ortho  3,4,4',5-tetra-CB 
126  penta-CB  non-ortho  3,3',4,4',5-penta-CB 
169  hexa-CB  non-ortho  3,3',4,4',5,5'-hexa-CB 
mono-ortho substituted PCBs 
105  penta-CB  mono-ortho  2,3,3',4,4'-penta-CB 
114  penta-CB  mono-ortho  2,3,4,4',5-penta-CB 
118  penta-CB  mono-ortho  2,3',4,4',5-penta-CB 
123  penta-CB  mono-ortho  2,3',4,4',5-penta-CB 
156  hexa-CB  mono-ortho  2,3,3',4,4',5-hexa-CB 
157  hexa-CB  mono-ortho  2,3,3',4,4',5'-hexa-CB 
167  hexa-CB  mono-ortho  2,3',4,4',5,5'-hexa-CB 
189  hepta-CB  mono-ortho  2,3,3',4,4',5,5'-hepta-
5 In ecological risk assessments, the dioxin-like PCBs should be included in a cumulative 
assessment with all other chemicals that act via the same mechanism of action (i.e., AHR 
agonists such as polychlorinated dibenzo dioxins (PCDDs) and furans (PCDFs)).  
Presently, the most credible approach for assessing mixtures of dioxin-like chemicals is 
to apply a toxicity equivalence approach in which the concentrations of the individual 
dioxin-like congeners are converted to TCDD toxicity equivalence concentrations (TEC) 
using a toxicity equivalence factor (TEF) or a relative potency factor (RPF).  Guidance 
for applying the toxicity equivalence approach in ecological risk assessment is currently 
being prepared by EPA’s Risk Assessment Forum (U.S. EPA, 2003).  For complementary 
information on applying the  toxicity equivalence approach for assessment of PCDDs, 
PCDFs and dioxin-like PCBs, see van den Berg et al. (1998) and U.S. EPA (2000, 2001). 
Certain dioxin-like PCBs may act via multiple toxicity pathways.  Hence, while the 12 
dioxin-like PCBs are known to cause dioxin-like toxicity via the AHR, the 8 mono-ortho 
dioxin-like congeners may also act via non-AHR mechanisms to cause additional effects. 
As other toxic pathways for PCBs are elucidated, it is possible that dioxin-like PCBs may 
be found to cause adverse effects on additional ecologically-relevant endpoints.  At this 
time, information about the mechanisms of action and dose-response relationships in 
ecological receptors is insufficient to allow assessment of dioxin-like PCBs on the basis 
of non-AHR mediated pathways.  However, a number of studies of effects of PCB 
mixtures in wildlife species (including both laboratory and field exposure scenarios) have 
shown that most, if not all, toxicity caused by the mixtures (e.g. Aroclors) can be 
attributed to the TCDD equivalence concentration (TEC) of the mixture (Walker et al., 
1996; Tillitt et al., 1996; Tillitt and Wright, 1997; Giesy and Kannan, 1998). 
2.5  Non-Dioxin-Like Congeners 
The 197 PCB congeners which were not discussed in the previous section are currently 
referred to collectively as “non-dioxin-like” congeners.  These congeners are also often 
referred to as the “non-coplanar” or “ortho-substituted” congeners.  However, experts 
attending an international World Health Organization Consultation in 2001 established 
preference for the biologically-based term “non-dioxin-like” for several reasons, the most 
compelling being that even the non-ortho substituted PCBs are not strictly planar in 
configuration and some ortho-substituted PCB congeners have both dioxin-like and non-
dioxin-like activity (WHO, 2001).  As more research is conducted on these congeners it is 
likely that they will be classified more specifically into additional subsets based on 
toxicological effects endpoints (e.g., endocrine active PCBs; neurotoxic PCBs, 
immunotoxic PCBs; etc.) and/or mechanisms of action (estrogen receptor 
agonists/antagonists; serotonin biosynthesis inhibitors; etc.).  Current knowledge of non-
AHR-mediated effects of PCBs are the subject of Part 4 of this report. 
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3.  Detection, Transport and Disposition of PCBs in the Environment 
3.1  Analytical Methods for Detection of PCBs 
The various congener-specific analytical methods have been reviewed in detail elsewhere; 
several recent reviews are summarized here.  The second edition of a book dedicated to 
this topic,  Analytical Chemistry of PCBs, was published in 1997 (Erickson, 1997). 
Analytical methods are reviewed more briefly in a recent compilation of papers presented 
at a PCB workshop held in 2000 (Robertsen and Hansen, 2001).  Frame (2001) presents a 
concise overview of various analytical methods for quantifying PCBs, dedicating most of 
the text to “the ultimate PCB mixture analytical procedure” he refers to as 
Comprehensive, Quantitative, Congener-Specific (CQCS) PCB Analysis.  EPA’s Method 
1668A is highlighted and is predicted to become the “gold standard” of CQCS PCB 
analysis.  A more pragmatic presentation of congener-specific methods is provided by 
Beliveau (2001) of EPA’s Region 1.  Beliveau also provides an examination of Aroclor 
and partial congener analyses as well as full references for the various EPA methods for 
analysis of PCBs in various environmental matrices.  Hansen (1999) has compiled 
important details to consider in interpreting and presenting congener-specific data.  U.S. 
EPA Region 9's Biological Technical Assistance Group has also reviewed various 
analytical methods for routine congener-specific analysis and report that methods 
currently available are adequate and cost-effective (Valoppi et al., 1999).  This report also 
presents a phased approach for PCB congener-specific analysis specifically for use within 
the context of performing site-specific ecological risk assessments. 
As European and U.S. regulatory agencies move away from “Total PCB” and Aroclor 
analyses, it has been recognized that analysis of all possible PCB congeners may not be 
necessary, possible or practical on a routine basis (WHO, 2001).  The analysis of subsets 
of PCB “indicator-congeners”, selected based on abundance, prevalence and distribution 
in the environment, has been proposed as an approach for hazard identification, 
estimating exposure, and prioritizing risk assessment activities (WHO, 2001).  It should 
be noted that the WHO expert panel did not support the use of “indicator congeners” for 
measures of toxicity however, due to the limited data available on the effects of non-
dioxin-like congeners (WHO, 2001).  Hence, while it has been recognized that a full 209 
congener-specific analysis may not be necessary for all phases or tiers of risk assessment 
and efforts are underway to identify subsets of congeners to measure for particular 
applications (e.g. hazard identification, screening, remedial monitoring, etc.), 
characterization of the relative contribution of non-dioxin-like PCB congeners to PCB 
mixture toxicity remains a significant data gap.  Several different lists of potential 
indicator congeners have emerged from various sources (WHO, 2001; Frame, 2001; 
Valoppi et al., 1999; NOAA, 1993; McFarland and Clarke, 1989).  To date, EPA has not 
established a definitive list of “indicator congeners”, standardized an approach for 
analyzing PCBs nor has any of EPA’s programs promulgated a congener-specific method 
(Beliveau, 2001). 
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3.2  Fate, Transport and Disposition in the Environment 
Historically (1930s-1970s), commercial mixtures of PCBs were used worldwide as 
dielectric fluids in capacitors and transformers, heat transfer fluids, hydraulic fluids, 
lubricating oils, and additives in pesticides, paints, copy paper, adhesives and plastics 
(ATSDR, 2000; Hansen, 1999).  PCBs have been released into the environment as a 
consequence of historical use and disposal; releases of newly manufactured PCBs having 
been stopped within the U.S. since banning of the manufacture and use of PCBs in 
commerce in the 1970s.  Examples of primary sources include landfills, hazardous waste 
sites, incineration of PCB-containing wastes, leakage from old electrical equipment and 
improper disposal or spills (ATSDR, 2000). 
The fate of individual PCB congeners is determined by both environmental processes and 
the physical-chemical properties of individual congeners.  In general, PCB congeners that 
are more highly chlorinated and have fewer ortho substitutions are less volatile, less 
water soluble, bind more readily to organic particulate matter and are more amenable to 
anaerobic dechlorination processes (typically in buried sediments).  Thus, these congeners 
are more prominent in soils and sediments, less prominent in water and in the 
atmosphere, and have higher bioaccumulation factors (BAFs).  Congeners that are less 
chlorinated and have more ortho substitutions are more volatile, more water soluble and 
are much more readily metabolized in mammals.  Consequently, these congeners are 
more prominent in the atmosphere, surface waters and in fish from temperate waters 
(Hansen, 1999).  Hydrophobicity is the most important chemical property that controls 
bioavailability from water, sediment or soils.  Hydrophobicity can be estimated by the 
octanol-water partition coefficient, Kow.  Generally, log Kows for PCBs increase from 
approximately 3 to 9 as degree of chlorination increases (Hansen, 1999).  Hence, lower 
chlorinated PCBs having lower Kows are more bioavailable than higher chlorinated 
congeners having higher Kows.  PCBs that are highly hydrophobic are difficult to measure 
in water because of the very small concentrations in solution.  Conversely, concentrations 
in surficial sediments or soils are often measurable and can be used effectively to 
reference each PCB congener’s distribution to abiotic and biotic components of the 
ecosystem.  In aquatic ecosystems, concentrations measured in surficial sediments can be 
used to estimate average concentrations in water. 
Specifics regarding non-dioxin-like PCB congener disposition in environmental 
compartments and transfers among them are detailed by Hansen (1999).  A detailed 
discussion of the dynamics and interplay between these processes is beyond the scope of 
this document, but have been presented in detail elsewhere for PCBs generally (ATSDR, 
2000; Robertson and Hansen, 2001) and for non-dioxin-like congeners specifically 
(Hansen, 1999). 
3.3  Disposition in the Environment: Media 
Due to historical releases and redistribution among environmental compartments, PCBs 
are widely distributed in environmental media and biota.  Of the 209 possible congeners, 
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~113 are found in environmental media and/or biota (McFarland and Clarke, 1989). 
Reports of PCBs, either measured as total PCBs or Aroclors, in environmental media and 
biota are abundant in the literature.  Fewer congener-specific characterizations are found, 
especially in the older literature.  In the environment, PCBs are always found as mixtures 
of both dioxin-like and non-dioxin-like PCB congeners.  Hansen (1999) provides a more 
recent summary of the disposition of PCBs in the environment, with special emphasis on 
the non-dioxin-like congeners.  Hansen points out that global disposition may not be 
relevant to site-specific assessment, but there will always be an atmospherically derived 
background PCB concentration which will often be regionally similar.  While it is 
possible to generalize about specific congener fate, transport and disposition based on 
physical-chemical properties of PCBs, ultimately the congener profile of interest for a 
site-specific ecological risk assessment will be dependent upon the specific congeners 
present in the source material (e.g., which Aroclors were used/disposed of) and the 
physical and/or chemical processes relevant for the location.  For example, the congener 
profile present in media and biota at a site where only a single Aroclor mixture was ever 
used/disposed may be quite different from the profile found at a manufacturing plant 
which produced the full spectrum of PCB products.  The literature is also replete with 
reports of PCBs in environmental media and organisms from numerous sites around the 
world.  Physical, chemical and ecological similarities (e.g., sources, transport pathways, 
biological systems – lentic vs. lotic, etc.) between sites may serve as a basis for 
extrapolating congener profiles. 
3.4  Disposition in the Environment: Biota 
PCB toxicity cannot be determined simply by examining the environmental 
concentrations of the congeners.  Differential rates of uptake, metabolism and elimination 
will influence the congener profile to which target tissues are ultimately exposed. 
Detailed discussions of the disposition of PCBs in various taxa and the role of various 
toxicokinetic factors that influence the bioaccumulation of PCB congeners is beyond the 
scope of this report, but have been summarized elsewhere (Hansen, 1999; Robertson and 
Hansen, 2001; ATSDR, 2000).  Some generalizations can be made however.  Aquatic 
invertebrates serve as a major source of PCBs in food chains and seem to retain polar 
metabolites of metabolizable PCBs, which then biomagnify in the food chain.  Uptake of 
PCBs in fish and invertebrates occurs via contact with media (i.e., respiration of water; 
contact with sediment), but food chain transfer is a major contributor for predatory 
organisms.  Uptake of PCBs in piscivorous mammals and birds is primarily from 
ingestion of fish.  As a class of compounds, PCBs are relatively resistant to metabolism 
by animals and the resistence to metabolism increases with degree of chlorination.  Most 
congeners are metabolized to some extent and differential or selective metabolism among 
species appears to have the greatest influence on net PCB accumulation (Hansen, 1999). 
PCB congener profiles in mammals are generally similar, but species-specific differences 
in absorption, disposition and metabolism certainly exist.  The PCB congener profiles in 
fish differ considerably from birds and mammals and consistently include greater 
proportions of congeners that are more labile in mammals.  For example, measurements 
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of biota-sediment accumulation factors (BSAFs) for fish clearly demonstrate that very 
few PCB congeners are significantly metabolized, but that PCB 77 is a notable exception 
(Endicott and Cook, 1994; U.S. EPA, 1995c). 
Overviews of dose-, congener-, species- and time-dependent PCB profiles in aquatic and 
marine food chains is presented by Hansen (1999).  McFarland and Clarke (1989) provide 
a congener-specific summary of the occurrence and abundance of all 209 PCBs found in 
several classes of animals from various trophic levels collected from several different 
sites world-wide.  Although this paper presents only a “snapshot” of PCB profiles for 
organisms from specific sites, it provides a template of the sort of data one might desire 
to collect for an ecological risk assessment.  The literature pertaining to bioaccumulation 
and biotransformation of PCBs in birds has been reviewed by Barron et al. (1995). 
Bioaccumulation and clearance of 42 individual PCB congeners following exposure of 
American kestrels to a mixture of Aroclors has been characterized by Drouillard et al. 
(2001).  Congener-specific bioaccumulation of a number of individual PCB congeners in 
three trophic levels of an aquatic food web has been described and biotransfer factors for 
four water bird species determined (Zimmermann et al., 1997).  Numerous reports 
document PCB profiles in higher trophic level birds collected from the field (e.g., Custer 
et al., 2002; Herzke et al., 2002; Elliot et al., 2001; van den Brink and Bosveld, 2001). 
Information on the PCB profiles present in aquatic and avian species will also serve as a 
basis for examining exposure of wildlife mammals via ingestion of such species. 
4.  Biological Effects of Non-Dioxin-Like PCBs 
Some non-dioxin-like PCBs have been shown to elicit different types of responses than 
the dioxin-like PCBs, including neurological, neuroendocrine, endocrine, immunological 
and carcinogenic effects.  These effects occur via multiple toxicity pathways, not 
involving the AHR.  Currently, only a small number of individual non-dioxin-like PCBs 
have been linked to any one of these effects and it should be realized that a single 
congener may act through one or more pathways.  Likewise, some weak dioxin-like 
congeners, or their metabolites (i.e., mono-ortho chlorinated congeners), may also initiate 
toxicity via these pathways, independent of the AHR.  However, in order to assess risks 
posed via these toxicity pathways, the pathways must be demonstrated to be active in a 
particular organism or class of organisms.  Furthermore, dose-response relationships for 
toxicity elicited via these other pathways must be characterized to determine whether 
effects of non-dioxin-like PCBs are occurring at concentrations less than those elicited by 
dioxin-like PCBs that are always found in the environment along with the non-dioxin-like 
PCBs. 
While PCBs have been shown to affect various physiological system(s) in some classes of 
organisms, this is not necessarily the case for all taxa.  Table 3 summarizes the toxicity 
pathways that have, to date, been shown to be affected by non-dioxin-like PCBs and those 
organisms in which PCBs have elicited effects attributable to those toxicity pathways. 
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The following sections summarize what is currently known regarding the toxicity 
pathways activated by non-dioxin-like PCBs in different biological systems.  The 
congener-specific data provided represents the data that currently exists in the literature 
(i.e., only a very small number of individual congeners have been examined for activity 
through the various non-dioxin-like toxicity pathways).  Lack of mention of a particular 
congener in association with a toxicity pathway does not imply that the congener does not 
act through this pathway, rather that the congener has not been tested for activity via the 
pathway.  The data presented here should not be interpreted to be all-inclusive, as 
characterization of non-AHR-mediated effects of PCBs is an active area of research and 
new data appear in the literature daily. 
Table 3.  Toxicity Pathways Documented for Non-Dioxin-Like PCBs 
Organism Class 
Toxicity Pathway  Invertebrate  Fish  Birds  Mammals 
Narcosis  X  X  X  X 
Liver Effects  N/A  ?  ?  X 
Neurochemical / behavioral  ?  ?  ?  X 
Endocrine / Neuroendocrine  ?  hydroxy PCBs  ?  X 
Immunological  X  ?  ?  X 
4.1  Toxicity Pathways 
Narcosis is a non-specific mechanism of toxicity that may be elicited in any organism by 
any organic compound, including non-dioxin-like PCBs, at sufficiently high 
concentrations.  Other potential toxicity pathways, such as endocrine/neuroendocrine 
disruption, neurotoxicity, and immunotoxicity, of non-dioxin-like PCBs are currently 
being studied in all classes of organisms and as they are elucidated, some toxic effects of 
non-dioxin-like PCBs observed in any of these classes of organisms may be attributable 
to them.  Non-dioxin-like PCB toxicity occurring via other toxicity pathways has been 
established for mammals.  Although evidence for non-dioxin-like PCB activity via other 
toxicity pathways in birds, fish and invertebrates is mounting, the majority of information 
on PCB toxicity has not focused on measures of effects associated with these toxicity 
pathways.  Hence, most PCB toxicity data for birds characterize dioxin-like toxicity and 
those for fish characterize either narcosis (acute exposures; high concentrations) or 
dioxin-like toxicity (early life stage toxicity; low concentrations).  The bulk of existing 
data for invertebrates describe their general insensitivity to PCBs, with toxicity observed 
at high concentrations, consistent with narcosis as the mode of action.  It is assumed that 
non-dioxin-like PCB toxicity that occurs via any of the more specific toxicity pathways 
will occur at concentrations lower than those which induce narcosis (Carey et al., 1998). 
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4.1.1  Narcosis 
Narcosis, also referred to as  “baseline toxicity” or “anesthesia”, is elicited by organic 
chemicals in all organisms given sufficient exposure and assuming a more potent toxicity 
pathway is not initiated at a lower dose.  Narcosis is thought to be initiated through 
chemical-mediated perturbations of membrane-bound proteins, either through direct 
interactions or modification of the protein-membrane lipid interface or micro­
environment.  Narcotic effects are generally considered to be reversible until death 
occurs.  For aquatic organisms, narcosis has been characterized in laboratory toxicity 
tests, and relationships between octanol/water partition coefficients, lethality and critical 
body residues are well established.  The common toxicity pathway and established 
concentration-residue-response relationships allow mixtures of chemicals (including 
PCBs) to be assessed cumulatively using additivity approaches (DiToro and McGrath, 
2000; DiToro et al., 2000; Van Leeuwen et al., 1992).  Narcotic mode of action and 
toxicity are summarized concisely by Carey et al. (1998) and presented in detail in 
numerous reviews (DiToro and McGrath, 2000; DiToro et al., 2000; Bradbury et al., 
1989). 
Mammals & Birds - Examples of PCB-induced narcosis in laboratory studies for 
mammals and birds are generally not available because sufficiently high steady-state 
blood concentrations of PCBs can not be attained through oral exposures.  Under chronic 
exposure scenarios with lower doses, effects of PCBs via AHR-mediated toxicity 
pathways have been well documented.  Likewise, effects that may be found to occur via 
non-dioxin-like toxicity pathways as described in the following sections would also be 
expected to occur at concentrations below those which cause toxicity via narcosis (Carey 
et al., 1998).  Therefore, for most ecological risk assessment scenarios, mammalian and 
avian assessment endpoints should be based on toxicity endpoints other than narcosis. 
Fish - Lethality of PCB mixtures (e.g., Aroclors) and individual non-dioxin-like PCBs in 
fish following acute aqueous exposures are generally attributed to narcosis.  For example, 
there are numerous reports of Aroclor-induced lethality in fish (see ECOTOX/AQUIRE 
database: www.epa.gov/ECOTOX).  The symptomology observed in these tests shows 
responses characteristic of narcosis and the toxicity can be accurately described using 
related QSARs (Van Leeuwen et al., 1992; Veith et al., 1983).  Other toxic effects of non-
dioxin-like PCBs that occur at lower concentrations/doses and through longer exposures, 
which are elicited through other toxicity pathways (e.g. endocrine disruption), are 
beginning to be elucidated as described in the following sections.  It is anticipated that 
effects occurring via these more specific toxicity pathways would occur at concentrations 
below those which cause toxicity via narcosis (Carey et al., 1998). 
Invertebrates - Distinction between dioxin-like and non-dioxin-like PCBs in reference to 
invertebrate toxicity is obviated due to the apparent lack of an AHR-mediated toxicity 
pathway in this class of organisms.  Although AHR homologs have been identified in a 
variety of invertebrate species (Hahn, 1998) they apparently lack the ability to bind the 
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prototypical AHR ligands, 2,3,7,8-TCDD and $-naphthoflavone (Butler et al., 2001). 
Hence, all toxicity elicited by PCB in invertebrates is considered to occur via non-dioxin-
like toxicity pathways.  Several studies are of particular interest in evaluating the toxicity 
of individual congeners to invertebrates.  These studies include Borgmann et al. (1990; 
PCB 52 in Hyalella azteca), Dillon et al. (1990; PCBs 52, 101, 118, 138, 153, 180 in 
Daphnia magna), Dillon and Burton (1991; PCBs 18, 116, 128, 153, 171, 194 in Daphnia 
magna), Fisher et al. (1999; PCBs 1, 15, 47, 153 in Lubriculus variegatus), Smith and 
Johnston (1992; PCB 15 in shrimp, Crangon crangon) and Schweitzer et al. (1997; PCBs 
47 and 153 in purple sea urchin, Stongylocentrotus prupuratus).  The PCB concentrations 
used in these studies were very high (often exceeding water solubility) and the 
invertebrates were most often found to be unaffected by the PCBs.  A report by Hwang et 
al. (2001; PCB 153 in Chironomus riparius) is a recent addition to the database of effects 
of PCBs on invertebrate fecundity and development.  Comprehensive summaries of toxic 
effects caused by PCB mixtures and individual PCB congeners in a variety of 
invertebrates are provided by Niimi (1996) and Jarvinen and Ankley (1999).  In those 
cases where toxicity was observed in these studies, it occurred at relatively high 
concentrations and was consistent with narcosis (West et al., 1997; Fisher et al., 1999). 
Many of these studies have been summarized and evaluated by the U.S. EPA for their 
potential utility for deriving wildlife criteria values (U.S. EPA, 2002). 
4.1.2  Liver Effects 
Hepatotoxicity of commercial mixtures of PCBs in mammals is well documented and 
includes a number of endpoints including increased liver weight, biochemical changes 
(e.g., enzyme induction, porphyrin accumulation), histopathology, and tumors as 
compiled recently by ATSDR (2000).  However, congener-specific effects data, 
generally, and non-dioxin-like congener effects data, specifically, are quite limited. 
Furthermore, such endpoints are typically not used as measurement endpoints in 
ecological risk assessments because it is often difficult to clearly link these effects to 
adverse outcomes on either individuals or populations of ecological receptors.  Although 
not necessarily useful for ecological risk assessment, a brief summary of reports of liver 
effects, particularly those that may be useful in distinguishing dioxin-like effects from 
non-dioxin-like effects, is provided. 
A few studies utilizing various mammalian models have examined effects of specific 
congeners on liver endpoints.  The general trend is for the endpoints examined to be 
responsive to dioxin-like PCBs, but not non-dioxin-like PCBs (reviewed in ATSDR, 
2000).  Structure-activity relationships for PCB-induced biochemical and 
histopathological responses are not well established, but have been reviewed previously 
(Safe, 1994; Marks, 1985).  Liver effects in birds and fish have largely been described 
within the context of dioxin-like effects, or lack thereof.  Hence, several non-dioxin-like 
congeners have been assessed for their ability to cause non-specific liver lesions (e.g., 
weight changes, protein concentration changes) and/or induce CYP1A, but effects 
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specific to non-dioxin-like congeners have not been established.  These data for 
mammals, birds and fish are summarized below. 
Mammals - Both dioxin-like and non-dioxin-like PCBs are hepatic tumor promoters in 
rodents.  In two-year bioassays of Aroclors 1016, 1242, 1254 and 1260, all of these 
mixtures were considered carcinogenic, particularly in female rat livers.  When the doses 
of these mixtures were expressed on a TEC basis (i.e., dioxin-like PCBs only), the dose-
response relationship for Aroclor-induced tumors in female rat liver is similar to that 
observed for TCDD, except for the Aroclor 1016 mixture.  The Aroclor 1016 mixture 
contains the lower chlorinated PCBs and has little dioxin-like activity and the 
carcinogenic effect of this mixture may be attributed to the non-dioxin-like PCBs present. 
Unlike TCDD, liver tumors were observed in the male rats receiving Aroclor 1260, 
suggesting that these effects are mediated through pathways other than the Ah receptor. 
Other liver effects, including increased liver weight, biochemical changes (e.g., enzyme 
induction, porphyrin accumulation) were also observed in the aforementioned studies. 
Similar to the carcinogenic effects, the female rats were more sensitive than the males and 
Aroclor 1016 was much less potent than the other mixtures.  These studies suggest that 
the hepatic toxicity of mixtures of PCBs are largely due to the dioxin-like congeners in 
these mixtures (ATSDR, 2000).  In mammals, induction of liver enzymes distinct from 
cytochrome P4501A, namely cytochrome P450s 2A and 3B (CYP2A/3B), have been 
linked to non-dioxin-like PCBs (reviewed by Bandiera, 2001).  Although the molecular 
mechanism(s) underlying CYP2B/3A induction has not been elucidated, this endpoint, in 
the absence of CYP1A induction, could be used as a biomarker of non-dioxin-like PCB 
exposure and/or effects (WHO, 2001; Bandiera, 2001). 
Liver porphyrin accumulation in response to PCB exposure, both PCB mixtures and 
individual PCB congeners, has been studied in several mammalian species (see ATSDR, 
2000 for review).  Dioxin-like PCB congeners 105, 128 and 126, but not 77, cause 
porphyrin accumulation in rats (ATSDR, 2000; van Birgelen et al., 1996).  In contrast, 
non-dioxin-like PCB congeners 28, 118, 153 and 156 reportedly are not porphyrinogenic 
in rats.  While a strong association between AHR responsiveness and porphyrinogenic 
responses indicates that the porphyrinogenic response in mammals is largely AHR-
mediated (ATSDR, 2000), non-dioxin-like PCBs have been reported to greatly enhance 
AHR-mediated porphyrin accumulation.  It appears that both dioxin-like and non-dioxin-
like PCBs may affect the heme biosynthetic pathway via different molecular mechanisms 
(van Birgelen et al., 1996; Marks, 1985). 
Birds - While induction of cytochrome P450s isozymes other than 1A1 have been 
associated with exposure to non-dioxin-like PCBs in mammals, this relationship has not 
been established in birds.  Kennedy et al. (1996) have reported induction of EROD 
activity in chicken embryo hepatocytes treated with the non-dioxin-like congeners #2, 12, 
35, 37, 78, 79, 80, 66, 70, 110, 122, 128, 138, 139, 167, 170, 180, and 194.  Lorenzen et 
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al. (1997) report that PCBs 52, 54, 101, 136 and 153 failed to induce EROD activity or 
CYP1A protein in chicken embryo hepatocytes, but were able to induce porphyrin 
accumulation at high concentrations.  Quail exposed to PCB 153 displayed increased liver 
weights, but the occurrence of porphyria and CYP1A induction caused the authors to 
suspect that the PCB was contaminated with dioxin-like congeners, which was confirmed 
by chemical analysis (Elliot et al., 1997).  In ovo exposure of chicken eggs to PCB 153 
failed to cause liver lesions and other early life stage effects associated with exposure to 
dioxin-like congeners (Zhao et al., 1997). 
Like the CYP1A induction response, the porphyrinogenic response to PCB exposure in 
birds is not clearly associated with only the dioxin-like PCB congeners.  Several studies 
using chick embryo liver cells show that although dioxin-like PCB congeners are more 
potent porphyrinogenic agents, certain non-dioxin-like congeners (e.g., 66, 128, 153, 155, 
(non-dioxin-like) also possess porphyrinogenic activity, albeit much weaker (Goldstein et 
al., 1976; Kawanishi et al., 1978; Marks, 1985; Sassa et al., 1986).  Similarly, Miranda et 
al. (1987) have reported porphyrinogenic responses in Japanese quail exposed to both 
PCB 77 (dioxin-like) and 47 (non-dioxin-like).  Sassa et al. (1986) have used the chick 
embryo liver data to demonstrate that porphyrinogenic potency is correlated with chlorine 
substitution patterns that convey planarity of the PCB molecule.  Hence, while the 
structural determinants for porphyrinogenic potency of dioxin-like PCBs are the same as 
those which determine AHR responsiveness, it remains to be determined whether non-
dioxin-like PCBs may act on the heme biosynthetic pathway via other mechanisms as has 
been postulated to occur in mammals (van Birgelen et al., 1996). 
Fish - While induction of cytochrome P450s isozymes other than 1A1 have been 
associated with exposure to non-dioxin-like PCBs in mammals, this relationship has not 
been established in fish.  The ability of a few non-dioxin-like PCB congeners to induce 
CYP1A protein and/or EROD activity has been assessed.  PCBs 128 and 138 were tested 
in scup (Stenotomus chrysops) in vivo (Gooch et al., 1989); PCBs 128, 138, 153 and 170 
were tested in a zebrafish (Danio rerio) liver cell line (Henry et al., 2001) and PCB 153 
was tested in a topminnow (Poeciliopsis lucida) hepatoma cell line (Bruschweiler et al., 
1996).  None of the non-dioxin-like congeners tested were effective at inducing fish 
CYP1A.  These data do not provide evidence linking non-dioxin-like PCB exposure in 
fish tissues to an enzyme induction biomarker as has been established in mammals, but 
they do reinforce the association of CYP1A induction as an effect that is specific to 
dioxin-like congeners in fish. 
4.1.3  Endocrine / Neuroendocrine Function 
A broad range of xenobiotics, including PCBs, may have the potential to alter endocrine 
function.  Endocrine disrupting activity is of concern for ecological risk assessment 
because most physiological, developmental and reproductive processes in both 
invertebrates and vertebrates are controlled by one or more endocrine systems.  Endocrine 
disruptors may directly or indirectly mimic or inhibit the production or action of a variety 
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of steroids including estrogens, progestins, androgens, adrenal steroids and thyroid 
hormones.  Individual PCB congeners may act through one or more endocrine pathways 
to cause effects and individual congeners in a mixture may have opposing activities (e.g., 
estrogenic and anti-estrogenic).  These actions may occur via a variety of molecular or 
biochemical events in a number of cells, tissues or organs within a given endocrine 
system (e.g., hypothalamus, pituitary, gonad, thyroid, adrenal, steroid metabolism, etc.). 
Characterizing the effects of PCBs on the various endocrine systems is further 
complicated by the fact that the concentrations, actions and potencies of steroids and 
other endocrine active compounds can vary considerably during different life stages and 
reproductive cycles.  Thus, the potential for PCBs to disrupt endocrine activity will need 
to be determined on a congener-specific basis to establish structure-activity relationships 
for specific endocrine effects and subsequently the means to assess cumulative effects of 
mixtures of environmental congeners. 
It is well established that PCBs, including both dioxin-like and non-dioxin-like congeners 
and hydroxylated metabolites of some congeners (i.e., hydroxylated PCBs) may affect 
endocrine systems in vertebrates (Cooke et al., 2001).  Issues related to the 
characterization of endocrine-related effects of PCBs have been reviewed in detail 
elsewhere (Brouwer et al., 1998; ATSDR, 2000; Cooke et al., 2001).  PCB-induced 
endocrine effects are summarized below for mammals, birds fish and invertebrates.  The 
summaries provided focus on effects that have been attributed specifically to non-dioxin-
like PCB congeners, but Aroclor effects data are presented if they are the only data 
available that demonstrates the potential for PCB-induced endocrine effects for a class of 
organisms. 
Mammals - Reports of the effects of PCBs on various endocrine systems in mammals 
following exposure to Aroclors are abundant and have been reviewed elsewhere 
(ATSDR, 2000; Brouwer et al., 1998).  These reports provided the impetus for further 
investigating the mechanisms underlying such effects and for determining specific PCB 
congeners that elicit effects through a common pathway.  The Aroclor studies will not be 
discussed further here.  The remainder of this section will focus on describing 
endocrine/neuroendocrine effects for which causality has been unambiguously linked to 
non-dioxin-like PCB congeners. 
Reproductive - Effects of non-dioxin-like PCBs in a variety of mammalian endocrine 
systems have been described (Cooke et al., 2001; Fischer et al., 1998).  Much of the 
individual congener data has been collected from in vitro model systems in an attempt to 
elucidate the means by which disruption of endocrine pathways can be initiated.  For 
example, several studies have demonstrated that hydroxylated PCBs bind to the estrogen 
receptor (Layton et al., 2002; Yoon et al., 2001; Matthews and Zacharewski, 2000; 
Kuiper et al., 1998). Other studies have demonstrated that hydroxylated PCBs inhibit 
estrogen sulfation that may result in increases in target tissue concentrations of estradiol 
(Kester et al., 2000).  Congener specific data from in vivo studies are limited. 
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Uterotrophic effects of PCB 153 have been observed in immature female rats 
(Soontornchat et al., 1994).  In addition, developmental exposures to a mixture of PCBs 
has induced feminization of male behavior in rats (Kaya et al., 2002).  However, it is 
possible that these effects are mediated through the actions of dioxin-like PCBs present in 
these mixtures.  While there are limited in vivo studies on individual non-dioxin-like 
PCBs, it is possible that alterations in the developing reproductive and neurological 
systems from in utero and lactational exposure to PCBs is due, in part, to these effects on 
estrogen catabolism and receptor interactions. 
Initial studies indicated that PCB 138 has an antagonistic effect on androgen receptor 
activity in transiently co-transfected Chinese Hamster ovary cells (Bonefeld-Jorgensen et 
al., 2001).  Portigal et al. (2002) demonstrated in an in vitro system that Aroclors 1260, 
1254, 1248, and 1242 antagonize androgen receptor-mediated gene transcription induced 
by dihydrotestosterone.  Three individual congeners lacking dioxin-like activity 
(congeners 42, 128 and 138) have been tested and were also anti-androgenic in this 
system (Portigal et al., 2002).   A number of studies have demonstrated that either 
mixtures of PCBs or individual congeners inhibit rat testicular steroid biosynthesis and 
the authors of the studies suggest this effect is not mediated through the AHR (Kovaevi 
et al., 1995; Andric et al., 2000a,b).  However, the importance of these mechanisms in the 
reproductive and developmental effects of PCBs is uncertain.  
Thyroid - A number of studies have demonstrated that both dioxin-like and non-dioxin-
like PCBs decrease serum thyroid hormone concentrations.  The non-dioxin-like PCBs, 
while much less potent than the dioxin-like PCBs, produce greater than a 90% decrease in 
serum thyroxine concentrations.  In comparison, the dioxin-like PCBs are much more 
potent, but only produce a 40-50% decrease in serum thryoxine (Craft et al., 2002).  Two 
different mechanisms have been proposed for the decreases in serum thyroid hormones by 
PCBs.  A number of studies have demonstrated that PCB mixtures or individual 
congeners increase hepatic thyroxine glucuronidation by inducing UDPGT isoforms 
(Craft et al., 2002; Hood and Klaassen, 2000).  The induction of thryoxine 
glucuronidation increases the biliary elimination of thyroid hormones (Vansell and 
Klaassen, 2002a,b).  A second mechanism may be the interaction of PCBs with 
transthyretin (Chauhan et al., 2000).  Transthyretin is a serum transport protein for thyroid 
hormones and certain non-dioxin-like PCBs can displace thyroid hormones from binding 
to this site and potentially increasing their hepatic uptake and elimination (Chauhan et al., 
2000).  However, while a number of non-dioxin-like congeners have this activity, so do 
some dioxin-like congeners (Chauhan et al., 2000).  Other potential mechanisms may 
involve alterations in thyroid hormone sulfation pathways by PCBs (Kester et al., 2000).  
Thyroid hormones are critical in the development of the central nervous system.  Perinatal 
exposures to PCBs that result in decreases in thyroid hormones in neonatal rats is 
associated with decreases in ototoxicity (Goldey et al., 1995).  The ototoxicity can be 
ameliorated by administration of exogenous thyroxine, suggesting the ototoxicity is due 
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to the hypothyroxinemia (Goldey and Crofton, 1998).  In humans, background exposures 
to PCBs have been associated with decreases in serum thyroid hormones in infants 
(Koopman-Esseboom et al., 1994).  While these changes are also associated with 
neurological developmental delays (Koopman-Esseboom et al., 1997), it is uncertain 
whether these associations are causal.  Once again, few studies have examined individual 
non-dioxin-like PCBs for these developmental effects and the role of the dioxin-like 
chemicals present in these mixtures remains a confounder in ascribing these effects solely 
to the non-dioxin-like PCBs. 
Birds - Effects of PCBs on endocrine endpoints in birds is actively being explored, but 
currently available studies are largely limited to Aroclor or field exposures.  No studies 
describing endocrine effects attributable specifically by non-dioxin-like PCBs in birds 
have been reported. 
Reproductive - Plasma androgen and estrogen concentrations were unaffected in 
American kestrels (Falco sparverius) exposed to a mixture of Aroclors 1248, 1254 and 
1260 although the altered courtship behaviors, reproduction and fertility was attributed to 
non-persistent, non-dioxin-like congeners, based on bioaccumulation and clearance rates 
measured for individual PCB congeners (Fisher et al., 2001; Fernie et al., 2001a,b; 
Drouillard et al., 2001).  No correlations were found between steroid hormone 
concentrations and PCB concentrations in common tern eggs collected from the field 
(French et al., 2001; Nisbet et al., 1996).  However, common tern embryos collected from 
a site contaminated with an unusual mixture of congeners comprised predominantly of 
less chlorinated congeners displayed ovarian morphology indicative of feminization. 
While correlations between feminization and individual PCB congeners measured in the 
embryos were not statistically significant, the authors noted that the strongest correlation 
was found between concentrations of  PCB 29, which is structurally similar to PCBs 30 
and 61.  The hydroxylated metabolites of these two congeners are strongly estrogenic 
(Korach et al., 1988).  The authors also report that extracts of these tern eggs were found 
to be estrogenic in an estrogen receptor binding assay (Hart et al., 1998). 
Thyroid - The role of thyroid hormones in normal behavior and development in wildlife 
and the evidence supporting potential disruption of this pathway by xenobiotics have 
been reviewed recently (Colborn, 2002; Brucker-Davis, 1998).  Abnormal thyroid gland 
development and aberrant thyroid hormone levels have been widely reported in birds; 
however, clear association between such endpoints and ecologically relevant adverse 
effects and specific environmental contaminants are lacking (Colborn, 2002). 
Association between thyroid effects and PCB exposure is further complicated by the fact 
that thyroid disruption may be mediated via both AHR- and non-AHR-mechanisms. 
In ovo exposure of chicken embryos to Aroclors 1242 and 1254 decrease plasma 
thyroxine concentrations and reduce activity of hepatic type I monodeiodinase, an enzyme 
responsible for thyroid hormone homeostasis (Gould et al., 1999; Quinn et al., 2002). 
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Neither PCB 54 or PCB 80 (non-dioxin-like) caused similar effects; however, the authors 
propose that the effects are mediated via a non-dioxin-like mechanism because PCB 77 
(dioxin-like) also did not produce the effects.  Aroclor 1254 has also been reported to 
decrease plasma thyroid hormone (T3; triiodothyronine) and  increase thyroid gland 
weight in adult mallards (Fowles et al., 1997). 
The use of Aroclor mixtures in all the studies described above does not allow a clear 
causal relationship between exposure to non-dioxin-like PCB congeners and endocrine 
effects in birds to be established at this time.  However, Janz and Bellward (1996a,b) 
have provided a body of evidence demonstrating that in ovo exposure of birds to TCDD 
had no effect on plasma thyroid hormone concentrations, plasma sex hormone 
concentrations or hepatic estrogen receptors in several species of birds (chicken, pigeon, 
great blue heron).  Taken together, these data implicate non-dioxin-like congeners in the 
etiology of endocrine effects observed in birds exposed to Aroclors.    
Fish - A variety of xenobiotics cause endocrine disruption in fish, but data regarding 
endocrine activity of PCBs are generally limited and the majority of existing data are for 
Aroclors. 
Reproductive - In Atlantic salmon the non-dioxin-like PCB congeners 58, 104, 112 and 
188 were not estrogenic as measured by induction of the egg yolk protein vitellogenin, a 
hallmark for estrogenic activity in oviparous animals.  However, the authors note that the 
route of exposure that was used (intraperitoneal) may not have provided an accurate 
assessment (Norrgren et al., 1999).  Hydroxylated metabolites of PCB 9, 15, 18 and 61 
have been tested for their ability to bind to Atlantic croaker estrogen receptor, but only 
hydroxylated PCB 61 displayed affinity (Loomis and Thomas, 1999).  Hydroxylated PCB 
30 also has affinity for Atlantic croaker progestogen receptor (Thomas et al., 1998). 
Hydroxylated PCBs, OH-30, OH-50, OH-72 and OH-112 were found to induce 
vitellogenin in rainbow trout hepatocytes in vitro and OH-30 was more active than the 
other congeners (Andersson, et al., 1999).  Hydroxylated metabolites of PCB 30 and PCB 
61 were estrogenic in vivo, as measured by vitellogenin induction, in rainbow trout 
(Oncorhynchus mykiss) with OH-PCB 30 approximately 100-fold more potent than 
OH-PCB 61 (Carlson and Williams, 2001). 
Thomas and co-workers have tested several Aroclor mixtures for their ability to bind 
progesterone, estrogen and androgen receptors from the marine fishes, spotted seatrout 
(Cynoscion nebulosus) and Atlantic croaker (Micropogonias undulatus) (Thomas, 2000; 
Sperry and Thomas, 1999; Loomis and Thomas, 1999; Pinter and Thomas, 1997). 
Overall, the Aroclors tested (1210 and 1254) either showed no or very low binding 
affinity toward these fish receptors (Thomas, 2000).  Aroclor 1254 bound to a small 
degree to carp estrogen receptor, but the affinity was so low that incomplete binding 
curves were not obtainable (Kloas et al., 2000).  Thomas and co-workers have also 
complemented these binding studies with in vivo studies that demonstrate that Aroclor 
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1254 interferes with the neuroendocrine system in fish at the level of the hypothalamus 
and results in effects throughout the brain-pituitary-gonadal axis of Atlantic croaker 
(Khan et al., 2001; Khan and Thomas, 2001, 2000, 1996).  These studies with Aroclors 
serve well as screens for potential endocrine activity within the mixture of PCB 
congeners, but do not allow an assessment of the activity of specific non-dioxin-like 
congeners. 
Thyroid - Abnormal thyroid gland development and aberrant thyroid hormone levels have 
been widely reported in fish; however, clear association between such endpoints and 
ecologically relevant adverse effects and specific environmental contaminants are lacking 
(Colborn, 2002).  The role of thyroid hormones in normal behavior and development in 
wildlife and the evidence supporting potential disruption of this pathway by xenobiotics 
have been reviewed recently  (Colborn, 2002; Brucker-Davis, 1998).  While disruption of 
the thyroid hormone system in fish by PCB mixtures (Besselink et al., 1996) and dioxin-
like PCBs (Palace et al., 2001; Adams et al., 2000) has been reported, effects of non-
dioxin-like PCBs are essentially unexplored. 
With the exception of a few hydroxylated metabolites, virtually all studies of potential 
effects of PCBs on fish endocrine systems have been conducted using Aroclors.  The 
Aroclor data indicate that PCB mixtures do have endocrine activity in fish, but do not 
allow assignment of the activity to either dioxin-like or non-dioxin-like congeners, since 
both types of PCBs  may act as endocrine disruptors (Cooke et al., 2001).  The lack of 
congener-specific data on endocrine activity in fish also precludes making informed 
cross-species comparisons or extrapolations. 
Invertebrates - The vertebrate steroid hormones (e.g., estrogens, androgens, etc.) are 
found in some invertebrate phyla.  In echinoderms and deuterostomes they perform 
essentially the same functions (i.e., sex differentiation and reproduction) as in vertebrates, 
but their functions in other invertebrate phyla are not clear.  In invertebrates, many 
processes and functions controlled by hormones are unique to this class of organisms. 
Therefore, any comprehensive assessment of xenobiotics to act as potential endocrine 
disruptors, must include studies in these systems.  Given that invertebrates do not possess 
an AHR that binds prototypical dioxin-like compounds (Butler et al., 2001), it may be 
concluded that any endocrine effects observed in invertebrates do not occur via an AHR-
mediated pathway.  
Endocrine disruption by environmental contaminants in invertebrates has received less 
attention than for vertebrates, hence very little data are available regarding endocrine 
disruption in general, and data on the potential endocrine activity of PCBs and/or their 
metabolites are even more scarce.  To date, studies on endocrine disruption in 
invertebrates have focused on disruption of growth and/or developmental processes (e.g., 
molting, metamorphosis and regeneration) and reproduction in insects and crustaceans 
which are known to be controlled by hormones.  Aroclor 1242 and the non-dioxin-like 
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congener, PCB 29, has been reported to increase molting time, a process regulated by 
ecdysteroid hormones, in Daphnia magna (Zou and Fingerman, 1997a,b).  The authors 
hypothesized that this effect occurred as a result of competitively blocking the 
endogenous ecdysteroids from binding to the ecdysteroid receptor (EcR).  Oberdorster et 
al. (1999) tested the ability of Aroclor 1254 to interact with the Drosophila EcR and 
activate gene transcription in vitro and found no effect, neither agonistic nor antagonistic, 
on the reporter-gene.  Aroclors 1242 and 1254 are mixtures of both dioxin-like and non-
dioxin-like congeners, with PCB 29 present in 1242 but not in 1254.  Hence both studies 
provide some information regarding what PCB congeners may be potential ecdysone 
pathway disruptors in invertebrates.  
Summary - PCBs have been shown to have the potential to disrupt the endocrine systems 
of fish, birds and mammals.  Conclusive evidence for PCB-induced endocrine effects in 
invertebrates is lacking.  For fish and birds, endocrine activity cannot currently be 
assigned to specific PCB congeners, because virtually all studies of effects on endocrine 
endpoints have been conducted using Aroclors.  However, hydroxylated metabolites of 
certain PCB congeners appear to be consistently estrogenic across animal classes.  In 
mammals, more data on individual congeners are available and some structure-activity 
relationships are emerging, but the total number of congeners that have been assessed for 
effects on the various endocrine systems is quite small relative to the number of 
congeners present in the environment. 
4.1.4  Neurochemical / Neurobehavioral Function 
A number of studies have demonstrated associations between PCB exposure and 
developmental delays in humans.  One of the difficulties in interpreting theses studies is 
the co-exposure to dioxins.  In experimental animals, both dioxin and non-dioxin-like 
PCBs induce developmental neurotoxicity (reviewed in Seegal, 2001; Fischer et al., 
1998).  The present data, while suggesting that non-dioxin-like PCBs are developmental 
neurotoxicants, do not allow for a rigorous analysis of the role of the non-dioxin-like vs. 
dioxin-like PCBs in these effects. 
Mammals - Both dioxin-like and non-dioxin-like PCBs have been shown to have 
biochemical effects on the central nervous system.  A number of in vitro studies have 
demonstrated that some of the non-dioxin-like PCBs are neuroactive.  Some PCBs 
decrease catecholamine concentrations, particularly dopamine, in the central nervous 
system (Seegal et al., 1986;  Seegal, 2001; Fischer et al., 1998).  Structure-activity 
relationship studies indicate that the non-dioxin-like PCBs are the more active congeners 
(Shain et al., 1991).  Others have reported alterations in calcium, protein kinase C, and 
phorbol ester signaling in brain tissues by the non-dioxin-like PCBs (Kodavanti and 
Tilson, 1997; Fischer et al., 1998).  These studies suggest potential mechanisms by which 
the non-dioxin-like PCBs could be neurotoxic.  However, the available data on the 
developmental neurotoxicity of individual PCBs is limited.  While qualitative 
descriptions of the developmental neurotoxicity of the non-dioxin-like PCBs is possible, 
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quantitatively describing these effects following exposure to complex mixtures of PCBs 
is currently not possible. 
Birds - Neurotoxic effects of non-dioxin-like PCBs in birds have not been reported in the 
literature.  Aroclor 1254 has been demonstrated to reduce neurotransmitter concentrations 
in brains of ring doves, and the author of this study suggests that these biochemical 
affects could result in abnormal behaviors (Heinz et al., 1980).  Consistent with this 
hypothesis, Aroclor exposures have elicited behavioral effects in birds.  Male kestrels 
exposed to a mixture of Aroclors 1248, 1254 and 1260, exhibited more sexual and flight 
behaviors than control animals (Fisher et al., 2001) and Aroclor 1254 affected courting 
and nesting behaviors in mourning doves (Tori and Peterle, 1983), but because PCB 
mixtures were used in these studies, it is impossible to attribute the effects to any specific 
congener(s). 
Fish - As mentioned previously, Thomas and co-workers have demonstrated that Aroclor 
1254 affects the neuroendocrine system in Atlantic croaker.  Endocrine effects have been 
linked to specific actions on neural tissues (e.g. hypothalamus) and neurotransmitter 
synthesis pathways (Khan et al., 2001; Khan and Thomas, 2001, 2000, 1996).  These 
studies demonstrate PCBs can affect neural tissues in fish and provide a mechanistic 
connection between the neurotoxicity and impaired gonadal growth observed in fish 
exposed to Aroclor 1254.  However, because these studies were conducted with a PCB 
mixture, the neurological effects cannot be attributed specifically to non-dioxin-like PCB 
congeners. 
Invertebrates - A recent study (Smith et al., 1999) demonstrated that exposure of the 
embryonic marine invertebrate, Spisula, to Aroclor 1254 resulted in decreased growth of 
serotonergic cells.  The effect of Aroclor 1254 was dose-dependent, but it is unknown 
whether the effect is attributable to dioxin-like PCBs, non-dioxin-like PCBs, or both. 
However, the absence of a functional AHR in invertebrates (Butler et al., 2001) indicates 
the effects are likely mediated through non-dioxin-like pathway(s).  Regardless of the 
PCB congener(s) involved, this biochemical effect has not been linked to adverse 
outcomes on either individuals (e.g. mortality) or populations (e.g. fecundity) of 
invertebrates, hence the toxicological significance of the effect for this class of organisms 
remains to be established. 
Summary - Neurotoxic effects of PCB mixtures in mammals have provided much of the 
impetus for exploring effects of non-dioxin-like PCB congeners.  Neurochemical effects 
of several non-dioxin-like congeners have been characterized in a number of mammalian 
cells/tissues (Fischer et al., 1998; Seegal, 2001).  Neurotoxic effects of PCBs, dioxin-like 
or non-dioxin-like, have not been reported in birds.  To date, reports of PCB-induced 
neurotoxicity in fish and invertebrates are limited to biochemical effects of PCB mixtures 
on specific neuroendocrine or neurological cells/tissues. 
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4.1.5  Immune Function 
Of environmental contaminants studied thus far, PCBs are among the most potent 
immunotoxicants (Carey et al., 1998).  They have been documented to affect the immune 
systems of multiple species of mammals, birds and fish (Tryphonas, 1995).  These effects 
may include structural alterations of components (e.g., thymus, lymphocytes) or altered 
function (e.g., antibody production, hypersensitivity) of the immune system.  The 
mechanism(s) by which PCBs are thought to cause immunotoxicity are described by 
Tryphonas and Feeley (2001).  Effects of various Aroclors on several morphologic and 
functional endpoints of rodent, guinea pig, rabbit and chicken immune systems are 
summarized by Tryphonas and Feely (2001) and reviewed in detail elsewhere 
(Tryphonas, 1994).     
Mammals - Immunotoxic effects of PCBs have been well studied in rodents and 
primates.  The mammalian evidence indicates that PCBs may have a number of effects on 
the immune system and that the immune system is one of the most sensitive targets for 
PCB-induced toxicity (Tryphonas and Feely, 2001).  Immunotoxicity data has been 
collected from studies with Aroclors as well as from individual congeners.  In general, 
higher chlorinated Aroclors (i.e., 1248, 1254 and 1260) are more immunotoxic than lower 
chlorinated Aroclors (i.e., 1016, 1232 and 1248) (Carey et al., 1998).  Much of the 
congener specific data focus on dioxin-like PCBs.  These data are consistent with the 
Aroclor data, indicating that the dioxin-like congeners exert their immunotoxic effects via 
the AHR and are more potent immunotoxicants than the non-dioxin-like congeners. 
While the data on the dioxin-like congeners include measures of functional effects on the 
immune system, the data for non-dioxin-like PCBs focus solely on changes in 
biochemical parameters of specific immune components and have been observed at high 
concentrations of PCBs.  For example, Ganey and colleagues (Fischer et al., 1998) have 
demonstrated that PCBs alter neutrophil degranulation through a mechanism independent 
of the AHR.  However, it is uncertain if these changes result in alterations in immune 
integrity.  In addition, some of the  non-dioxin-like congeners appear to antagonize the 
immunotoxic effects of dioxin-like congeners, but do so through non-AHR mediated 
mechanisms (Tryphonas and Feely, 2001).  Smialowicz et al. (1997) demonstrated that 
PCB 153 can enhance the immune response to sheep red blood cells as determined in a 
plaque forming cell assay.  PCB effects on the mammalian immune system have been 
reviewed in detail elsewhere (Tryphonas, 1994; Tryphonas and Feely, 2001). 
Birds - Effects of PCBs on immunological endpoints in birds is largely unexplored and 
existing studies are limited to Aroclor or field exposures.  No studies of immunological 
effects caused specifically by non-dioxin-like PCBs in birds have been reported.  PCB 
concentrations in plasma and eggs of field exposed Caspian terns have been correlated 
with immunotoxicity measured by T lymphocyte function and antibody production; 
however, the changes in the specific endpoints measured also correlated with DDE 
concentrations in the terns (Grasman and Fox, 2001).  Antibody production was affected 
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in kestrels exposed either via food or in ovo, to a mixture of Aroclors 1248, 1254 and 
1260 (Smits and Bortolotti, 2001).  In contrast, antibody production was not affected in 
progeny of chickens fed Aroclors 1232, 1242, 1248 and 1254, although spleen and bursa 
weights were found to be decreased by these Aroclors (Harris et al., 1976).  Subchronic 
exposure of adult male mallards to Aroclor 1254 resulted in no immunotoxic effects, as 
measured by a battery of immune endpoints, several of which were the same as those 
measured in the tern and kestrel studies (Fowles et al., 1997).  Hence, no clear causal 
relationship between PCB exposure and immunotoxicity in birds has so far emerged. 
Because dioxin and dioxin-like PCB congeners have also been reported to cause immune 
effects in birds (Powell et al., 1996a,b; Hoffman et al., 1996; Nikolaidis et al., 1988), 
future studies that aim to assess the potential impacts of PCBs on bird immune function 
should be designed to discern immunological effects caused by dioxin-like and  non-
dioxin-like congeners. 
Fish - Effects of PCBs on immune function in fish have not been reported in the 
literature. 
Invertebrates - Effects of non-dioxin-like PCB 15 on the immune system of the common 
shrimp (Crangon crangon) has been described (Smith and Johnston, 1992).  In the same 
study, dioxin-like PCB 77 also caused the same effect, but this response was considered 
equivocal based on the magnitude of the response and dose-response relationship 
observed. 
Summary - PCB mixtures have been demonstrated to cause immunological effects in 
mammals, but effects attributable specifically to non-dioxin-like congeners have not been 
clearly delineated.  Reports of effects of PCB mixtures on immune endpoints in birds are 
mixed and no data are available which describe exposure and/or effects specifically for 
non-dioxin-like congeners.  PCB-induced immune effects in fish are unstudied.  A single 
study provides some evidence that non-dioxin-like congeners may have immune effects 
in invertebrates. 
4.2  Relative Toxicity of Non-Dioxin-Like vs. Dioxin-Like PCBs 
As evidenced by the data review provided in the previous section, most studies of the 
toxicity of PCBs have focused on either commercial mixtures, concentrated 
environmental samples or laboratory defined mixtures.  All three of these approaches 
result in mixtures that contain both dioxin-like and non-dioxin-like PCBs.  In these 
studies, it is often difficult to qualitatively determine the relative contribution of dioxin-
like and non-dioxin-like PCBs to the toxic effects observed.  Quantitative assessments of 
the role of these chemicals is simply not possible using these study designs.  Although 
PCBs are frequently characterized as dioxin-like and non-dioxin-like, this 
characterization is an overly simplified description of a structurally diverse class of 
chemicals.  The toxicity of a number of the dioxin-like PCBs have been fairly well 
characterized.  However, these congeners represent just 12 of the 209 possible PCBs. 
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The remaining PCBs are structurally diverse and may act via one or more toxicity 
pathways; hence from a mode of action perspective, characterizing them as a single class 
is inappropriate.  Most of the congener-specific toxicity data for these non-dioxin-like 
PCBs is focused on less than a dozen congeners.  Hence, while a compilation of data 
comparing dioxin-like and non-dioxin-like effects levels (e.g., NOAELs, LOAELs, 
EC50s, etc.) would be helpful in assessing the relative toxicity of PCB congeners, the 
limited amount of congener-specific data currently available severely limits the utility of 
such an exercise. 
Presently, it is unclear how to apply this limited congener-specific toxicity data to the 
assessment of complex mixtures found in environmental samples.  In the following 
discussion, these limitations are described in greater detail for specific toxicity responses. 
One approach taken in these analyses is to examine the contribution of the dioxin-like 
effects to the toxic response and determine if the use of the toxicity equivalence 
methodology would be protective of wildlife species. 
4.2.1  Mammals 
Relatively few studies are available that characterize the toxicity of non-dioxin-like PCBs 
individually.  Studies of the commercial mixtures indicate that the more sensitive effects 
described to date are mediated by the dioxin-like chemicals present in these mixtures. 
For example two different lots of Aroclor 1254 have been examined in a series of studies 
(Burgin et al., 2001; Kodavanti et al., 2001).  These two lots differ in the concentrations 
of dioxin-like PCB congeners and PCDF contaminants.  The toxicity equivalence 
methodology adequately predicted some responses that were clearly mediated by the Ah 
receptor.  However, effects on thyroid hormones, oxidative stress, Ca
2+ buffering and 
phosphokinase C translocation in brain preparations were not predicted by the toxicity 
equivalence methodology.  It is uncertain whether these effects are due solely to the non-
dioxin-like chemicals or due to interactions between dioxin-like and the non-dioxin-like 
chemicals.  The data are presently insufficient to ascribe specific effects solely to the non-
dioxin-like PCBs present in these mixtures. 
Using the available data on neurotoxicological endpoints characterized in mammals, 
Giesy and Kannan (1998) performed an analysis of the relative toxicity of dioxin-like and 
non-dioxin-like PCBs to mink.  They concluded that it is unlikely for the neurotoxic 
effects caused by non-dioxin-like PCBs to be critical based on 1) the high concentrations 
of di-ortho substituted PCB congeners needed to elicit neurotoxic responses; 2) the 
propensity for the most neurotoxic congeners to be those that are less chlorinated and 
therefore more easily metabolized and excreted and less bioaccumulative; and 3) field 
studies indicating that neuroactive congeners do no accumulate to sufficient levels in feral 
animals (Giesy and Kannan, 1998). 
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4.2.2  Birds 
An evaluation of the relative importance of non-dioxin-like PCB congener toxicity in 
birds is hindered by lack of data.  Evidence from both laboratory and field studies is 
sufficient to conclude that PCBs produce a wide spectrum of toxic effects in birds, 
including effects that have been associated with non-dioxin-like PCBs in mammals (e.g., 
endocrine disruption, neurotoxicity, immunotoxicity).  However, the use of Aroclor or 
field exposures in virtually all studies of PCB effects in birds precludes characterizing the 
toxicity(ies) that are attributable specifically to non-dioxin-like congeners.  Additional 
studies are needed to establish that non-dioxin-like congeners are toxic in birds and to 
characterize the type(s) of effects endpoints that are affected by these congeners. 
Furthermore, it is necessary to demonstrate that non-dioxin-like effects result in whole 
organism responses that are ecologically relevant (i.e., adverse effects on survival, growth 
or reproduction) and to evaluate the potential for significant ecological outcomes (e.g. 
population effects) due to such effects. 
4.2.3  Fish 
Very few studies are available that characterize toxicity of non-dioxin-like PCB 
congeners in a manner sufficient for use in ecological risk assessment.  The only 
individual non-dioxin-like congeners studied in vivo in fish are PCBs 4, 52, 128, 138 and 
170 (Gooch et al., 1989; Zabel et al., 1995).  Each of these studies has been summarized 
(Jarvinen and Ankley, 1999; U.S. EPA, 2002) and evaluated by the U.S. EPA for their 
potential utility for deriving wildlife criteria values (U.S. EPA, 2002).  It should be noted 
that endpoints evaluated in these studies were those associated with AHR-mediated 
(dioxin-like) toxicity (e.g. induction of CYP1A; early life stage edema/mortality 
syndrome) and typically these endpoints have been unresponsive to the non-dioxin-like 
congeners.  So, while these studies can be used to establish no effects levels for dioxin-
like endpoints and in establishing effects endpoints that may be used to distinguish 
among dioxin-like and non-dioxin-like congeners, they do not provide for characterizing 
non-dioxin-like effects.  Available data indicate that non-dioxin-like PCBs and/or their 
hydroxylated metabolites have the potential to cause toxicity via disruption of 
neuroendocrine pathways, but further studies are needed to demonstrate that the effects 
endpoints described to date result in whole organism responses that are ecologically 
relevant (i.e., adverse effects on survival, growth or reproduction) and to evaluate the 
potential for significant ecological outcomes (e.g. population effects) due to such effects. 
4.2.4  Invertebrates 
It has been demonstrated that a wide variety of invertebrates including amphipods, 
cladocerans, midges, mosquito larvae, sandworms, oligochaete worms, snails, clams and 
grass shrimp are insensitive to dioxin and PCB-induced toxicity (West et al., 1997; 
Barber et al., 1998; Fisher et al., 1999; see U.S. EPA, 1993 and 2002 for summaries and 
references prior to 1998).  Reported effects of PCBs in invertebrates include arrested 
development and decreased growth, depressed reproduction and decreased survival.  In 
those cases where toxicity was observed in these studies, it occurred at high 
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concentrations and was attributed to narcosis (West et al., 1997; Fisher et al., 1999). 
Clear evidence that PCBs can cause endocrine disruption, neurotoxicity or 
immunotoxicity in invertebrates at sub-narcotic concentrations is generally lacking.  
Acute effects occur at low mg/kg tissue concentrations and chronic effects generally 
occur at concentrations about an order of magnitude lower than those that cause acute 
toxicity (these effects concentrations are also consistent with narcosis as the mode of 
action) .  For aquatic organisms, these tissue-residue concentrations are associated with 
:g/L water concentrations (Jarvinen and Ankley, 1999).  While toxicity has been 
evaluated for a few individual PCBs congeners (Dillon et al., 1990; Dillon and Burton, 
1991; Fisher et al., 1999), the majority of studies have been conducted with PCB 
mixtures (e.g., Aroclors; see Jarvinen and Ankley, 1999) which does not allow 
determination of the toxicity contributed by non-dioxin-like congeners. 
5.  Consideration of Non-Dioxin-Like PCBs in Ecological Risk Assessment 
5.1  Non-Dioxin-Like Effects Endpoints 
Collectively, data currently available from field studies and PCB mixture exposures 
provide evidence to indicate that wildlife species are susceptible to effects from non-
dioxin-like PCBs.  However, the existing data are inadequate for use in quantitative 
ecological risk assessments for several reasons.  First, many of the non-dioxin-like PCB 
effects so far described are specific to particular cells/tissues and/or species (e.g., 
biochemical changes; neurotoxic effects) or could also be induced by dioxin-like PCBs 
(e.g., thyroid effects; immunotoxic effects).  Furthermore, lack of well-defined dose-
response relationships for most of the non-dioxin-like effects does not allow for 
assessment of the sensitivity of non-dioxin-like effects relative to dioxin-like effects. 
Finally, even for endpoints for which there may be well defined dose-response 
relationships (e.g. certain biochemical, cellular and tissue level effects), clear linkages 
between such effects and typical assessment endpoints in ecological risk assessments 
(e.g., growth, survival and reproduction) have not been demonstrated. 
5.2  Relative Contribution of Dioxin-Like and Non-Dioxin-Like PCBs 
5.2.1.  Exposure 
Environmental PCB congener profiles: 1) often deviate considerably from original 
commercial PCB mixtures; 2) always include both non-dioxin-like PCBs and dioxin-like 
PCBs; 3) are often predominately non-dioxin-like congeners on a mass basis. 
Acknowledging the fact that commercial PCB mixtures (e.g., Aroclors) do not represent 
environmental exposures, experts at a recent WHO consultation concluded that additional 
toxicological studies using such mixtures should not be considered relevant from an 
environmental risk assessment perspective (WHO, 2001).  The consultation 
recommended that future studies aimed at determining exposure levels at which non­
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dioxin-like effects occur be conducted using reconstituted mixtures resembling 
environmental exposures (WHO, 2001).  Any evaluation of exposures to the non-dioxin-
like PCBs must also include consideration of factors which may vary among the dioxin-
like and non-dioxin-like congeners, such as: 1) appropriate dose metric, e.g. lighter 
chlorinated, relatively volatile, less persistent congeners may be more appropriately 
measured in air and water than sediments or soils; 2) temporal relationship between 
exposure and effects, e.g., exposures to some neurotoxic non-dioxin-like congeners 
during development appear to cause permanent effects; 3) sensitive organisms and/or life 
stages, e.g., disruption of thyroid system during developmental stages may affect 
neurological development.  However, the modes of action and dose-response 
relationships by which non-dioxin-like effects are elicited must be better defined before 
many of these exposure considerations can be accommodated in risk assessments.  
5.2.2.  Effects 
As documented in Section 4, the available data provide evidence that PCB mixtures are 
likely active via several potential modes of action in mammalian, avian and piscine 
wildlife.  Due to exposure regimens (e.g. Aroclors) and/or effect endpoints, it is rarely 
possible, however, to attribute any effects specifically to non-dioxin-like PCB congeners. 
Several previous analyses have indicated that reproductive and/or developmental effects 
of Aroclors on fish, birds and mammals can be attributed to the TEC (TCDD equivalence 
concentration) concentration of the mixture, suggesting that the dioxin-like congeners 
were primarily responsible for the Aroclor toxicity.  However, as documented in Section 
4, to date non-dioxin-like effects have rarely been looked for (especially in non-
mammalian species) and dose-response relationships that are necessary to evaluate 
relative thresholds among effects are non-existent.  The WHO consultation (2001) 
acknowledged these data gaps and recommended that studies should be conducted with 
the goal of determining if adverse effects caused by non-dioxin-like PCBs occur at 
exposure levels less than those caused by dioxin-like PCBs.  In summary, the data 
currently available are not sufficient to assess the relative contributions of dioxin-like and 
non-dioxin-like congeners to PCB mixture toxicity with any degree of certainty. 
5.2.3.  Risk 
Although current evidence indicates that the greatest potential for effects on endpoints of 
most concern for ecological receptors (e.g., growth, survival, reproduction) from 
exposure to PCB mixtures is from the dioxin-like congeners (Giesy and Kannan, 1998; 
Rice et al., 2002), risk estimates based solely on the 12 dioxin-like PCBs may 
underestimate the total PCB risk.  Given that non-dioxin-like PCBs always occur as 
mixtures with dioxin-like PCBs and the dioxin-like effects occur at extremely low 
concentrations, some have assumed that assessment based on the dioxin-like congeners 
will be protective against potential effects from the non-dioxin-like congeners (Giesy and 
Kannan, 1998).  Others recommend a dual track assessment of both the dioxin-like PCBs 
and total PCBs (Rice et al., 2002), because so little is currently known regarding the 
potential effects of the non-dioxin-like congeners.  A dual analysis of risks based on total 
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PCBs and on toxicity equivalence concentrations for dioxin-like PCBs is an approach that 
may be taken to assess PCB mixtures (Beltman et al., 1997; Brunstrom and Halldin, 
2000; Finley et al., 1997;  Giesy and Kannan, 1998; note, however, that these examples 
do not incorporate the 1998 taxa-specific WHO TEFs).  EPA currently recommends this 
combined approach for assessing PCB cancer risks to humans (U.S. EPA, 1996).  As 
more information becomes available about the toxicity mechanisms and relative potency 
of specific non-dioxin-like PCB congeners, alternative methods for assessing their risk 
will likely emerge. 
Currently, the lack of data regarding the toxicity endpoints and dose-response 
relationships for non-dioxin-like PCBs precludes performing quantitative ecological risk 
assessments for these congeners, either individually or cumulatively.  This problem is not 
unique to ecological risk assessment.  A 2001 WHO consultation was convened to 
evaluate the toxicological properties of non-dioxin-like PCBs in the context of human 
health risk assessment (WHO, 2001).  Experts at this workshop considered and evaluated 
the available exposure, toxicity and epidemiological data for non-dioxin-like PCBs.  It 
was concluded that an in-depth evaluation of all scientific data on PCBs needs to be 
conducted before a decision can be made as to the necessity or possibility of conducting 
separate risk assessments for non-dioxin-like PCBs. 
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APPENDIX 1:  Nomenclature & Log Kows 
PCB NOMENCLATURE: HOMOLOGS 
IUPAC #  IUPAC Name  CASRN  IUPAC #  IUPAC Name  CASRN 
Monochlorobiphenyl  27323-18-8  Hexachlorobiphenyl  26601-64-9 
Dichlorobiphenyl  25512-42-9  Heptachlorobiphenyl  28655-71-2 
Trichlorobiphenyl  25323-68-6  Octachlorobiphenyl  55722-26-4 
Tetrachlorobiphenyl  26914-33-0  Nonachlorobiphenyl  53742-07-7 
Pentachlorobiphenyl  25429-29-2 
PCB NOMENCLATURE: MIXTURES 
IUPAC #  IUPAC Name  CASRN  IUPAC #  IUPAC Name  CASRN 
Aroclor 1016  12674-11-2  Aroclor 1248  12672-29-6 
Aroclor 1210  147601-87-4  Aroclor 1250  165245-51-2 
Aroclor 1216  151820-27-8  Aroclor 1252  89577-78-6 
Aroclor 1221  11104-28-2  Aroclor 1254  11097-69-1 
Aroclor 1231  37234-40-5  Aroclor 1260  11096-82-5 
Aroclor 1232  11141-16-5  Aroclor 1262  37324-23-5 
Aroclor 1240  71328-89-7  Aroclor 1268  11100-14-4 
Aroclor 1242  53469-21-9  Aroclor (unspecified)  12767-79-2 
PCB NOMENCLATURE: DIOXIN-LIKE PCBs 
IUPAC #  IUPAC Name  CASRN  IUPAC #  IUPAC Name  CASRN 
77  3,3',4,4'-Tetrachlorobiphenyl  32598-13-3  118  2,3',4,4',5-Pentachlorobiphenyl  31508-00-6 
81  3,4,4',5-Tetrachlorobiphenyl  70362-50-4  123  2,3',4,4',5'-Pentachlorobiphenyl  65510-44-3 
126  3,3',4,4',5-Pentachlorobiphenyl  57465-28-8  156  2,3,3',4,4',5-Hexachlorobiphenyl  38380-08-4 
169  3,3',4,4',5,5'-Hexachlorobiphenyl  32774-16-6  157  2,3,3',4,4',5'-Hexachlorobiphenyl  68782-90-7 
105  2,3,3',4,4'-Pentachlorobiphenyl  32598-14-4  167  2,3',4,4',5,5'-Hexachlorobiphenyl  52663-72-6 
114  2,3,4,4',5-Pentachlorobiphenyl  74472-37-0  189  2,3,3',4,4',5,5'-Heptachlorobiphenyl  39635-31-9 
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PCB NOMENCLATURE & log Kows: CONGENERS 
IUPAC #  IUPAC Name  CASRN  log KOW  IUPAC #  IUPAC Name  CASRN  log KOW 
Monochlorobiphenyls  35  3,3',4-Trichlorobiphenyl  37680-69-6  5.82 
1  2-Chlorobiphenyl  2051-60-7  4.46  36  3,3',5-Trichlorobiphenyl  38444-87-0  5.88 
2  3-Chlorobiphenyl  2051-61-8  4.69  37  3,4,4'-Trichlorobiphenyl  38444-90-5  5.83 
3  4-Chlorobiphenyl  2051-62-9  4.69  38  3,4,5-Trichlorobiphenyl  53555-66-1  5.76 
Dichlorobiphenyls  39  3,4',5-Trichlorobiphenyl  38444-88-1  5.89 
4  2,2'-Dichlorobiphenyl  13029-08-8  4.65  Tetrachlorobiphenyls 
5  2,3-Dichlorobiphenyl  16605-91-7  4.97  40  2,2',3,3'-Tetrachlorobiphenyl  38444-93-8  5.66 
6  2,3'-Dichlorobiphenyl  25569-80-6  5.06  41  2,2',3,4-Tetrachlorobiphenyl  52663-59-9  5.69 
7  2,4-Dichlorobiphenyl  33284-50-3  5.07  42  2,2',3,4'-Tetrachlorobiphenyl  36559-22-5  5.76 
8  2,4'-Dichlorobiphenyl  34883-43-7  5.07  43  2,2',3,5-Tetrachlorobiphenyl  70362-46-8  5.75 
9  2,5-Dichlorobiphenyl  34883-39-1  5.06  44  2,2',3,5'-Tetrachlorobiphenyl  41464-39-5  5.75 
10  2,6-Dichlorobiphenyl  33146-45-1  4.84  45  2,2',3,6-Tetrachlorobiphenyl  70362-45-7  5.53 
11  3,3'-Dichlorobiphenyl  2050-67-1  5.28  46  2,2',3,6'-Tetrachlorobiphenyl  41464-47-5  5.53 
12  3,4-Dichlorobiphenyl  2974-92-7  5.22  47  2,2',4,4'-Tetrachlorobiphenyl  2437-79-8  5.85 
13  3,4'-Dichlorobiphenyl  2974-90-5  5.29  48  2,2',4,5-Tetrachlorobiphenyl  70362-47-9  5.78 
14  3,5-Dichlorobiphenyl  34883-41-5  5.28  49  2,2',4,5'-Tetrachlorobiphenyl  41464-40-8  5.85 
15  4,4'-Dichlorobiphenyl  2050-68-2  5.30  50  2,2',4,6-Tetrachlorobiphenyl  62796-65-0  5.63 
Trichlorobiphenyls  51  2,2',4,6'-Tetrachlorobiphenyl  68194-04-7  5.63 
16  2,2',3-Trichlorobiphenyl  38444-78-9  5.16  52  2,2',5,5'-Tetrachlorobiphenyl  35693-99-3  5.84 
17  2,2',4-Trichlorobiphenyl  37680-66-3  5.25  53  2,2',5,6'-Tetrachlorobiphenyl  41464-41-9  5.62 
18  2,2',5-Trichlorobiphenyl  37680-65-2  5.24  54  2,2',6,6'-Tetrachlorobiphenyl  15968-05-5  5.21 
19  2,2',6-Trichlorobiphenyl  38444-73-4  5.02  55  2,3,3',4-Tetrachlorobiphenyl  74338-24-2  6.11 
20  2,3,3'-Trichlorobiphenyl  38444-84-7  5.57  56  2,3,3',4'-Tetrachlorobiphenyl  41464-43-1  6.11 
21  2,3,4-Trichlorobiphenyl  55702-46-0  5.51  57  2,3,3',5-Tetrachlorobiphenyl  70424-67-8  6.17 
22  2,3,4'-Trichlorobiphenyl  38444-85-8  5.58  58  2,3,3',5'-Tetrachlorobiphenyl  41464-49-7  6.17 
23  2,3,5-Trichlorobiphenyl  55720-44-0  5.57  59  2,3,3',6-Tetrachlorobiphenyl  74472-33-6  5.95 
24  2,3,6-Trichlorobiphenyl  55702-45-9  5.35  60  2,3,4,4'-Tetrachlorobiphenyl  33025-41-1  6.11 
25  2,3',4-Trichlorobiphenyl  55712-37-3  5.67  61  2,3,4,5-Tetrachlorobiphenyl  33284-53-6  6.04 
26  2,3',5-Trichlorobiphenyl  38444-81-4  5.66  62  2,3,4,6-Tetrachlorobiphenyl  54230-22-7  5.89 
27  2,3',6-Trichlorobiphenyl  38444-76-7  5.44  63  2,3,4',5-Tetrachlorobiphenyl  74472-34-7  6.17 
28  2,4,4'-Trichlorobiphenyl  7012-37-5  5.67  64  2,3,4',6-Tetrachlorobiphenyl  52663-58-8  5.95 
29  2,4,5-Trichlorobiphenyl  15862-07-4  5.60  65  2,3,5,6-Tetrachlorobiphenyl  33284-54-7  5.86 
30  2,4,6-Trichlorobiphenyl  35693-92-6  5.44  66  2,3',4,4'-Tetrachlorobiphenyl  32598-10-0  6.20 
31  2,4',5,-Trichlorobiphenyl  16606-02-3  5.67  67  2,3',4,5-Tetrachlorobiphenyl  73575-53-8  6.20 
32  2,4',6-Trichlorobiphenyl  38444-77-8  5.44  68  2,3',4,5'-Tetrachlorobiphenyl  73575-52-7  6.26 
33  2,3',4'-Trichlorobiphenyl  38444-86-9  5.60  69  2,3',4,6-Tetrachlorobiphenyl  60233-24-1  6.04 
34  2,3',5'-Trichlorobiphenyl  37680-68-5  5.66  70  2,3',4',5-Tetrachlorobiphenyl  32598-11-1  6.20 
71  2,3',4',6-Tetrachlorobiphenyl  41464-46-4  5.98  107  2,3,3',4',5-Pentachlorobiphenyl  70424-68-9  6.71 
72  2,3',5,5'-Tetrachlorobiphenyl  41464-42-0  6.26  108  2,3,3',4,5'-Pentachlorobiphenyl  70362-41-3  6.71 
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PCB NOMENCLATURE & log Kows: CONGENERS 
IUPAC #  IUPAC Name  CASRN  log KOW  IUPAC #  IUPAC Name  CASRN  log KOW 
73  2,3',5',6-Tetrachlorobiphenyl  74338-23-1  6.04  109  2,3,3',4,6-Pentachlorobiphenyl  74472-35-8  6.48 
74  2,4,4',5-Tetrachlorobiphenyl  32690-93-0  6.20  110  2,3,3',4',6-Pentachlorobiphenyl  38380-03-9  6.48 
75  2,4,4',6-Tetrachlorobiphenyl  32598-12-2  6.05  111  2,3,3',5,5'-Pentachlorobiphenyl  39635-32-0  6.76 
76  2,3',4',5'-Tetrachlorobiphenyl  70362-48-0  6.13  112  2,3,3',5,6-Pentachlorobiphenyl  74472-36-9  6.45 
77  3,3',4,4'-Tetrachlorobiphenyl  32598-13-3  6.36  113  2,3,3',5',6-Pentachlorobiphenyl  68194-10-5  6.54 
78  3,3',4,5-Tetrachlorobiphenyl  70362-49-1  6.35  114  2,3,4,4',5-Pentachlorobiphenyl  74472-37-0  6.65 
79  3,3',4,5'-Tetrachlorobiphenyl  41464-48-6  6.42  115  2,3,4,4',6-Pentachlorobiphenyl  74472-38-1  6.49 
80  3,3',5,5'-Tetrachlorobiphenyl  33284-52-5  6.48  116  2,3,4,5,6-Pentachlorobiphenyl  18259-05-7  6.33 
81  3,4,4',5-Tetrachlorobiphenyl  70362-50-4  6.36  117  2,3,4',5,6-Pentachlorobiphenyl  68194-11-6  6.46 
Pentachlorobiphenyls  118  2,3',4,4',5-Pentachlorobiphenyl  31508-00-6  6.74 
82  2,2',3,3',4-Pentachlorobiphenyl  52663-62-4  6.20  119  2,3',4,4',6-Pentachlorobiphenyl  56558-17-9  6.58 
83  2,2',3,3',5-Pentachlorobiphenyl  60145-20-2  6.26  120  2,3',4,5,5'-Pentachlorobiphenyl  68194-12-7  6.79 
84  2,2',3,3',6-Pentachlorobiphenyl  52663-60-2  6.04  121  2,3',4,5',6-Pentachlorobiphenyl  56558-18-0  6.64 
85  2,2',3,4,4'-Pentachlorobiphenyl  65510-45-4  6.30  122  2,3,3',4',5'-Pentachlorobiphenyl  76842-07-4  6.64 
86  2,2',3,4,5-Pentachlorobiphenyl  55312-69-1  6.23  123  2,3',4,4',5'-Pentachlorobiphenyl  65510-44-3  6.74 
87  2,2',3,4,5'-Pentachlorobiphenyl  38380–02- 6.29  124  2,3',4',5,5'-Pentachlorobiphenyl  70424-70-3  6.73 
88  2,2',3,4,6-Pentachlorobiphenyl  55215-17-3  6.07  125  2,3',4',5',6-Pentachlorobiphenyl  74472-39-2  6.51 
89  2,2',3,4,6'-Pentachlorobiphenyl  73575-57-2  6.07  126  3,3',4,4',5-Pentachlorobiphenyl  57465-28-8  6.89 
90  2,2',3,4',5-Pentachlorobiphenyl  68194-07-0  6.36  127  3,3',4,5,5'-Pentachlorobiphenyl  39635-33-1  6.95 
91  2,2',3,4',6-Pentachlorobiphenyl  68194-05-8  6.13  Hexachlorobiphenyls 
92  2,2',3,5,5'-Pentachlorobiphenyl  52663-61-3  6.35  128  2,2',3,3',4,4'-Hexachlorobiphenyl  38380-07-3  6.74 
93  2,2',3,5,6-Pentachlorobiphenyl  73575-56-1  6.04  129  2,2',3,3',4,5-Hexachlorobiphenyl  55215-18-4  6.73 
94  2,2',3,5,6'-Pentachlorobiphenyl  73575-55-0  6.13  130  2,2',3,3',4,5'-Hexachlorobiphenyl  52663-66-8  6.80 
95  2,2',3,5',6-Pentachlorobiphenyl  38379-99-6  6.13  131  2,2',3,3',4,6-Hexachlorobiphenyl  61798-70-7  6.58 
96  2,2',3,6,6'-Pentachlorobiphenyl  73575-54-9  5.71  132  2,2',3,3',4,6'-Hexachlorobiphenyl  38380-05-1  6.58 
97  2,2',3,4',5'-Pentachlorobiphenyl  41464-51-1  6.29  133  2,2',3,3',5,5'-Hexachlorobiphenyl  35694-04-3  6.86 
98  2,2',3,4',6'-Pentachlorobiphenyl  60233-25-2  6.13  134  2,2',3,3',5,6-Hexachlorobiphenyl  52704-70-8  6.55 
99  2,2',4,4',5-Pentachlorobiphenyl  38380-01-7  6.39  135  2,2',3,3',5,6'-Hexachlorobiphenyl  52744-13-5  6.64 
100  2,2',4,4',6-Pentachlorobiphenyl  39485-83-1  6.23  136  2,2',3,3',6,6'-Hexachlorobiphenyl  38411-22-2  6.22 
101  2,2',4,5,5'-Pentachlorobiphenyl  37680-73-2  6.38  137  2,2',3,4,4',5-Hexachlorobiphenyl  35694-06-5  6.83 
102  2,2',4,5,6'-Pentachlorobiphenyl  68194-06-9  6.16  138  2,2',3,4,4',5'-Hexachlorobiphenyl  35065-28-2  6.83 
103  2,2',4,5',6-Pentachlorobiphenyl  60145-21-3  6.22  139  2,2',3,4,4',6-Hexachlorobiphenyl  56030-56-9  6.67 
104  2,2',4,6,6'-Pentachlorobiphenyl  56558-16-8  5.81  140  2,2',3,4,4',6'-Hexachlorobiphenyl  59291-64-4  6.67 
105  2,3,3',4,4'-Pentachlorobiphenyl  32598-14-4  6.65  141  2,2',3,4,5,5'-Hexachlorobiphenyl  52712-04-6  6.82 
106  2,3,3',4,5-Pentachlorobiphenyl  70424-69-0  6.64  142  2,2',3,4,5,6-Hexachlorobiphenyl  41411-61-4  6.51 
143  2,2',3,4,5,6'-Hexachlorobiphenyl  68194-15-0  6.60  179  2,2',3,3',5,6,6'-Heptachlorobiphenyl  52663-64-6  6.73 
144  2,2',3,4,5',6-Hexachlorobiphenyl  68194-14-9  6.67  180  2,2',3,4,4',5,5'-Heptachlorobiphenyl  35065-29-3  7.36 
145  2,2',3,4,6,6'-Hexachlorobiphenyl  74472-40-5  6.25  181  2,2',3,4,4',5,6-Heptachlorobiphenyl  74472-47-2  7.11 
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PCB NOMENCLATURE & log Kows: CONGENERS 
IUPAC #  IUPAC Name  CASRN  log KOW  IUPAC #  IUPAC Name  CASRN  log KOW 
146  2,2',3,4',5,5'-Hexachlorobiphenyl  51908-16-8  6.89  182  2,2',3,4,4',5,6'-Heptachlorobiphenyl  60145-23-5  7.20 
147  2,2',3,4',5,6-Hexachlorobiphenyl  68194-13-8  6.64  183  2,2',3,4,4',5',6-Heptachlorobiphenyl  52663-69-1  7.20 
148  2,2',3,4',5,6'-Hexachlorobiphenyl  74472-41-6  6.73  184  2,2',3,4,4',6,6'-Heptachlorobiphenyl  74472-48-3  6.85 
149  2,2',3,4',5',6-Hexachlorobiphenyl  38380-04-0  6.67  185  2,2',3,4,5,5',6-Heptachlorobiphenyl  52712-05-7  7.11 
150  2,2',3,4',6,6'-Hexachlorobiphenyl  68194-08-1  6.32  186  2,2',3,4,5,6,6'-Heptachlorobiphenyl  74472-49-4  6.69 
151  2,2',3,5,5',6-Hexachlorobiphenyl  52663-63-5  6.64  187  2,2',3,4',5,5',6-Heptachlorobiphenyl  52663-68-0  7.17 
152  2,2',3,5,6,6'-Hexachlorobiphenyl  68194-09-2  6.22  188  2,2',3,4',5,6,6'-Heptachlorobiphenyl  74487-85-7  6.82 
153  2,2',4,4',5,5'-Hexachlorobiphenyl  35065-27-1  6.92  189  2,3,3',4,4',5,5'-Heptachlorobiphenyl  39635-31-9  7.71 
154  2,2',4,4',5,6'-Hexachlorobiphenyl  60145-22-4  6.76  190  2,3,3',4,4',5,6-Heptachlorobiphenyl  41411-64-7  7.46 
155  2,2',4,4',6,6'-Hexachlorobiphenyl  33979-03-2  6.41  191  2,3,3',4,4',5',6-Heptachlorobiphenyl  74472-50-7  7.55 
156  2,3,3',4,4',5-Hexachlorobiphenyl  38380-08-4  7.18  192  2,3,3',4,5,5',6-Heptachlorobiphenyl  74472-51-8  7.52 
157  2,3,3',4,4',5'-Hexachlorobiphenyl  68782-90-7  7.18  193  2,3,3',4',5,5',6-Heptachlorobiphenyl  69782-91-8  7.52 
158  2,3,3',4,4',6-Hexachlorobiphenyl  74472-42-7  7.02  Octachlorobiphenyls 
159  2,3,3',4,5,5'-Hexachlorobiphenyl  39635-35-3  7.24  194  2,2',3,3',4,4',5,5'-Octachlorobiphenyl  35694-08-7  7.80 
160  2,3,3',4,5,6-Hexachlorobiphenyl  41411-62-5  6.93  195  2,2',3,3',4,4',5,6-Octachlorobiphenyl  52663-78-2  7.56 
161  2,3,3',4,5',6-Hexachlorobiphenyl  74472-43-8  7.08  196  2,2',3,3',4,4',5,6'-Octachlorobiphenyl  42740-50-1  7.65 
162  2,3,3',4',5,5'-Hexachlorobiphenyl  39635-34-2  7.24  197  2,2',3,3',4,4',6,6'-Octachlorobiphenyl  33091-17-7  7.30 
163  2,3,3',4',5,6-Hexachlorobiphenyl  74472-44-9  6.99  198  2,2',3,3',4,5,5',6-Octachlorobiphenyl  68194-17-2  7.62 
164  2,3,3',4',5',6-Hexachlorobiphenyl  74472-45-0  7.02  199  2,2',3,3',4,5,5',6'-Octachlorobiphenyl  52663-75-9  7.62 
165  2,3,3',5,5',6-Hexachlorobiphenyl  74472-46-1  7.05  200  2,2',3,3',4,5,6,6'-Octachlorobiphenyl  52663-73-7  7.20 
166  2,3,4,4',5,6-Hexachlorobiphenyl  41411-63-6  6.93  201  2,2',3,3',4,5',6,6'-Octachlorobiphenyl  40186-71-8  7.27 
167  2,3',4,4',5,5'-Hexachlorobiphenyl  52663-72-6  7.27  202  2,2',3,3',5,5',6,6'-Octachlorobiphenyl  2136-99-4  7.24 
168  2,3',4,4',5',6-Hexachlorobiphenyl  59291-65-5  7.11  203  2,2',3,4,4',5,5',6-Octachlorobiphenyl  52663-76-0  7.65 
169  3,3',4,4',5,5'-Hexachlorobiphenyl  32774-16-6  7.42  204  2,2',3,4,4',5,6,6'-Octachlorobiphenyl  74472-52-9  7.30 
Heptachlorobiphenyls  205  2,3,3',4,4',5,5',6-Octachlorobiphenyl  74472-53-0  8.00 
170  2,2',3,3',4,4',5-Heptachlorobiphenyl  35065-30-6  7.27  Nonachlorobiphenyls 
171  2,2',3,3',4,4',6-Heptachlorobiphenyl  52663-71-5  7.11  206  2,2',3,3',4,4',5,5',6-Nonachlorobiphenyl  40186-72-9  8.09 
172  2,2',3,3',4,5,5'-Heptachlorobiphenyl  52663-74-8  7.33  207  2,2',3,3',4,4',5,6,6'-Nonachlorobiphenyl  52663-79-3  7.74 
173  2,2',3,3',4,5,6-Heptachlorobiphenyl  68194-16-1  7.02  208  2,2',3,3',4,5,5',6,6'-Nonachlorobiphenyl  52663-77-1  7.71 
174  2,2',3,3',4,5,6'-Heptachlorobiphenyl  38411-25-5  7.11  Decachlorobiphenyls 
175  2,2',3,3',4,5',6-Heptachlorobiphenyl  40186-70-7  7.17  209  2,2',3,3',4,4',5,5',6,6'-Decachlorobiphenyl  2051-24-3  8.18 
176  2,2',3,3',4,6,6'-Heptachlorobiphenyl  52663-65-7  6.76  Footnotes: 
177  2,2',3,3',4,5',6'-Heptachlorobiphenyl  52663-70-4  7.08  Dioxin-like congeners are indicated by shading. 
178  2,2',3,3',5,5',6-Heptachlorobiphenyl  52663-67-9  7.14  log Kow values are from Hawker and Connell, 1988. 
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APPENDIX 2:  ERASC Request 
ECOLOGICAL RISK ASSESSMENT SUPPORT CENTER REQUEST FORM 
Request #0002: What are the non-dioxin-like effects of PCBs and how can they be evaluated in 
ecological risk assessments? 
Requestor : Bruce Duncan (R10) 
Background: EPA is developing a framework (using TEFs) to estimate the dioxin-like effects of PCB 
congeners. It is unclear whether the n-d-l effects can also be significant at the same time. The n-d-l effects 
will be from a different suite of congeners and via a different mechanism. The ERAF needs to move from 
evaluating PCBs as totals or aroclors (or even homologues) to evaluating congeners for the range of 
effects these congeners elicit. 
Expected Outcome: 
1. Describe the mode of action of non-dioxin-like compounds and types of effects in receptors (i.e., those 
congeners that "travel" with the listed dioxins, furans, and PCBs but just don't act via the Ah receptor). 
2. Discuss n-d-l toxicity relative to congener characteristics (something like a QSAR discussion). 
3. Discuss which congeners are of greatest concern (potency) for n-d-l toxicity (dose/response type 
information in the narcotic range of effects). 
4. Recommend how this scientific information on action, effects, and toxicity should be used in ecological 
risk assessment where PCBs are present (preferred use of the data, considerations for site-specific 
application, etc.). 
5. Discuss whether a general narcosis model can or should be used to evaluate n-d-l effects (as a function 
of range of contaminant concentration typically seen at low, medium, and highly contaminated sites) - see 
below as well. 
6. Provide an interactive video-conference on this topic and the one related to congener analytical 
methodology. 
Additional Comments : 
Summarize and update from the recent review of n-d-l activity.  Find an example or two of sites where TEF 
and n-d-l approaches were used or recommend how they would be used at an example site (example of 
application). 
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